image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
818c4417228507708574b886d0fa0047239827ed7b3fe8f02a05d0ee83f71bc8.png | simple | <table><tr><td>Substrate</td><td>Enzymatic activity(mU/μL)</td><td>Specific activity(mU/mg)</td></tr><tr><td>Laminarin</td><td>0.049 ± 0.002</td><td>290 ± 30</td></tr><tr><td>CMC</td><td>0.010 ± 0.001</td><td>59 ± 8</td></tr><tr><td>Pectin</td><td>0.0008 ± 0.0001</td><td>5 ± 1</td></t... | <table><tr><td>Substrate</td><td>Enzymatic activity(mU/μL)</td></tr><tr><td>Laminarin</td><td>0.049 ± 0.002</td></tr><tr><td>CMC</td><td>0.010 ± 0.001</td></tr><tr><td>Pectin</td><td>0.0008 ± 0.0001</td></tr><tr><td>Xylan</td><td>0.034 ± 0.002</td></tr><tr><td>pnPβGlu</td><td>0.020 ± 0.001</td></tr><tr><td>pnPβXyl</td>... | <table><tr><td>Specific activity(mU/mg)</td></tr><tr><td>290 ± 30</td></tr><tr><td>59 ± 8</td></tr><tr><td>5 ± 1</td></tr><tr><td>210 ± 20</td></tr><tr><td>120 ± 10</td></tr><tr><td>81 ± 9</td></tr><tr><td>90 ± 10</td></tr><tr><td>190 ± 21</td></tr></table> |
e8be84844a23c2e6eecb4e2e18ff4269559d360054e405393bd5c45fce33a1ea.png | complex | <table><tr><td rowspan="3">Parameters</td><td rowspan="3">Units</td><td colspan="4">Vinasse</td><td rowspan="2" colspan="2">Filter Cake (<i>n</i> = 9)</td><td rowspan="2" colspan="2">Bagasse (<i>n</i> = 9)</td><td rowspan="2" colspan="2">Straw (<i>n</i> = 12)</td><td rowspan="2" colspan="2">Recommendation</td></tr><tr>... | <table><tr><td rowspan="3">Parameters</td><td rowspan="3">Units</td></tr><tr></tr><tr></tr><tr><td>TS a</td><td>% FM d</td></tr><tr><td>VS b</td><td>% TS</td></tr><tr><td>COD c</td><td>g·L−1</td></tr><tr><td>C</td><td>% TS</td></tr><tr><td>N</td><td>% TS</td></tr><tr><td>P</td><td>% TS</td></tr><tr><td>S</td><td>% TS</... | <table><tr><td colspan="4">Vinasse</td><td rowspan="2" colspan="2">Filter Cake (n = 9)</td><td rowspan="2" colspan="2">Bagasse (n = 9)</td><td rowspan="2" colspan="2">Straw (n = 12)</td><td rowspan="2" colspan="2">Recommendation</td></tr><tr><td colspan="2">Autonomous (n = 6)</td><td colspan="2">Annexed (n = 15)</td></... |
f2b8436a687dc46f0d11c4710090b23136ecd025ef351852da5cc2a056da2f4e.png | simple | <table><tr><td>Variables</td><td>Rank†</td><td>P-value</td><td>HR</td><td>95% CI</td></tr><tr><td>Age</td><td>5</td><td>0.60</td><td>0.9</td><td>0.5-1.6</td></tr><tr><td>Male</td><td>3</td><td>0.10</td><td>2.5</td><td>0.8-7.7</td></tr><tr><td>Black</td><td>6</td><td>0.82</td><td>1.1</td><td>0.3-3.8</td></tr><tr><... | <table><tr><td>Variables</td><td>Rank†</td><td>P-value</td><td>HR</td><td>95% CI</td></tr><tr><td>Age</td><td>5</td><td>0.60</td><td>0.9</td><td>0.5-1.6</td></tr><tr><td>Male</td><td>3</td><td>0.10</td><td>2.5</td><td>0.8-7.7</td></tr><tr><td>Black</td><td>6</td><td>0.82</td><td>1.1</td><td>0.3-3.8</td></tr><tr><td>Ini... | <table><tr><td>Variables</td><td>Rank†</td><td>P-value</td><td>HR</td><td>95% CI</td></tr><tr><td>Uncontrolled hypertension</td><td>2</td><td>0.01</td><td>4.3</td><td>1.4-14</td></tr><tr><td>Trombotic microangiopathy</td><td>4</td><td>0.19</td><td>1.9</td><td>0.7-5.2</td></tr></table> |
7d4c484f571f44defcf785b37ec15fbae066ed4c4ed38856d93e56d301ce0b80.png | simple | <table><tr><td>Gene locus</td><td>Control (fructose)</td><td>Xylose 1 hour</td><td>Xylose 4 hours</td><td>Xylose + glucose 1 hour</td><td>Xylose + glucose 4 hours</td></tr><tr><td>An06g00620</td><td>0.08 ± 0.03</td><td>0.42 ± 0.07</td><td>0.38 ± 0.05</td><td>0.003 ± 0.00</td><td>0.03 ± 0.01</td... | <table><tr><td>Gene locus</td><td>Control (fructose)</td><td>Xylose 1 hour</td><td>Xylose 4 hours</td><td>Xylose + glucose 1 hour</td><td>Xylose + glucose 4 hours</td></tr><tr><td>An06g00620</td><td>0.08 ± 0.03</td><td>0.42 ± 0.07</td><td>0.38 ± 0.05</td><td>0.003 ± 0.00</td><td>0.03 ± 0.01</td></tr></table> | <table><tr><td>An15g04270</td><td>0.05 ± 0.00</td><td>0.04 ± 0.00</td><td>0.20 ± 0.00</td><td>0.04 ± 0.00</td><td>0.02 ± 0.00</td></tr><tr><td>An15g05440</td><td>0.34 ± 0.04</td><td>0.24 ± 0.03</td><td>0.56 ± 0.12</td><td>0.09 ± 0.05</td><td>0.19 ± 0.05</td></tr><tr><td>An11g03700</td><td>0.06 ± 0.00</td><td>0.04 ± 0.0... |
f5fdbe2034cd46eb929dfad7cda9a443d65175e8e3c5925b2a2949b22ec432d8.png | simple | <table><tr><td></td><td>Diploid, n (%)</td><td>Aneuploid, n (%)</td><td>p-value*</td></tr><tr><td>Age, quartiles</td><td></td><td></td><td></td></tr><tr><td> <58</td><td>178 (91)</td><td>18 (9)</td><td><0.001</td></tr><tr><td> 58 – 66</td><td>171 (83)</td><td>35 (17)</td><td></td></tr><tr><td> 66 – 75... | <table><tr><td></td><td>Diploid, n (%)</td><td>Aneuploid, n (%)</td><td>p-value*</td></tr></table> | <table><tr><td>Age, quartiles</td><td></td><td></td><td></td></tr><tr><td><58</td><td>178 (91)</td><td>18 (9)</td><td><0.001</td></tr><tr><td>58 – 66</td><td>171 (83)</td><td>35 (17)</td><td></td></tr><tr><td>66 – 75</td><td>145 (69)</td><td>66 (31)</td><td></td></tr><tr><td>≥ 75</td><td>144 (68)</td><td>68 (32)</td><t... |
447c38f8d97d56527c2f5a0310624e6d9427041c31e7022cd83dbd5cfae83a6d.png | simple | <table><tr><td>Container capacity, L</td><td>Number of 2MR disks</td><td>Target ppb</td></tr><tr><td>10</td><td>1/5</td><td>27</td></tr><tr><td>20</td><td>1⁄2</td><td>27</td></tr><tr><td>30</td><td>2/3</td><td>27</td></tr><tr><td>40</td><td>1</td><td>27</td></tr><tr><td>50</td><td>1</td><td>27</td></tr></table> | <table><tr><td>Container capacity, L</td></tr><tr><td>10</td></tr><tr><td>20</td></tr><tr><td>30</td></tr><tr><td>40</td></tr><tr><td>50</td></tr></table> | <table><tr><td>Number of 2MR disks</td><td>Target ppb</td></tr><tr><td>1/5</td><td>27</td></tr><tr><td>1⁄2</td><td>27</td></tr><tr><td>2/3</td><td>27</td></tr><tr><td>1</td><td>27</td></tr><tr><td>1</td><td>27</td></tr></table> |
e48b1bf6d1ba18a2ddb0b8d96713850ff0f1934e90ff54420c32fc423afbbd38.png | simple | <table><tr><td>Variable</td><td>B</td><td>SE</td><td>p</td><td>OR</td></tr><tr><td>Theme B vs all others</td><td>3.260</td><td>.744</td><td>.017</td><td>4.64</td></tr><tr><td>having some TFA questions</td><td>2.816</td><td>.757</td><td><.001</td><td>16.71</td></tr><tr><td>constant</td><td>-5.515</td><td>.841</td><td... | <table><tr><td>Variable</td><td>B</td><td>SE</td><td>p</td><td>OR</td></tr><tr><td>Theme B vs all others</td><td>3.260</td><td>.744</td><td>.017</td><td>4.64</td></tr></table> | <table><tr><td>Variable</td><td>B</td><td>SE</td><td>p</td><td>OR</td></tr><tr><td>having some TFA questions</td><td>2.816</td><td>.757</td><td><.001</td><td>16.71</td></tr><tr><td>constant</td><td>-5.515</td><td>.841</td><td><.001</td><td>.004</td></tr></table> |
06229a79b4c3ee4f59f1aa6c86d420006473534143898a34b40309bf65af56ff.png | simple | <table><tr><td>A</td><td>B</td><td>C</td><td>D</td><td>E</td><td>F</td><td>S</td><td>M</td><td>Range(where present)</td><td>Peak assignments<sup>*</sup></td></tr><tr><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>1299</td><td>–</td><td>–</td><td>1299</td><td>(CH<sub>2</s... | <table><tr><td>A</td><td>B</td><td>C</td><td>D</td><td>E</td><td>F</td><td>S</td><td>M</td></tr><tr><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>1299</td><td>–</td><td>–</td></tr><tr><td>–</td><td>–</td><td>–</td><td>–</td><td>1356</td><td>–</td><td>1355</td><td>–</td></tr><tr><td>1411</td><td>1415</td><td>141... | <table><tr><td>Range(where present)</td><td>Peak assignments*</td></tr><tr><td>1299</td><td>(CH2)n deformations</td></tr><tr><td>1356</td><td>Tertiary (CH) deformation</td></tr><tr><td>1411–1415</td><td>(CH2) or (CH3)</td></tr><tr><td>1438–1439</td><td>(CH2)</td></tr><tr><td>1443–1450</td><td>(CH2), (CH)</td></tr><tr><... |
426533f2e4abb9953dd37f8719f7cfce124aa1ca6642b2696e45bc952f3ac5b0.png | complex | <table><tr><td></td><td colspan="4">6-month change score</td><td rowspan="3">Difference of two groups (I – C)</td></tr><tr><td rowspan="2"></td><td colspan="2">Intervention Group</td><td colspan="2">Control Group</td></tr><tr><td>N*</td><td></td><td>N*</td><td></td></tr><tr><td>Laboratory data</td><td></td><td></... | <table><tr><td></td><td colspan="4">6-month change score</td><td rowspan="3">Difference of two groups (I – C)</td></tr><tr><td rowspan="2"></td><td colspan="2">Intervention Group</td><td colspan="2">Control Group</td></tr><tr><td>N*</td><td></td><td>N*</td><td></td></tr><tr><td>Laboratory data</td><td></td><td></td><td... | <table><tr><td>Social support score from Diabetes Care Profile (points)</td><td>2</td><td>2 (−0.0 to 0.4)</td><td>17</td><td>)</td><td> 0.4)</td></tr><tr><td>SF-12 Scores</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>PCS-12 (points)</td><td>203</td><td>0.6 (−0.4 to 1.6)</td><td>196</td><td>1.6 (0.6 to 2... |
6901e09cc31bd81df12550167e7219a03987b6f999f8862ed83398a2721a41b5.png | simple | <table><tr><td> </td><td> </td><td>Value</td></tr><tr><td>Age (years)</td><td> </td><td>41 (18–79)</td></tr><tr><td>Gender (n)</td><td>Male</td><td>64</td></tr><tr><td> </td><td>Female</td><td>73</td></tr><tr><td>Marital status (n)</td><td>Single</td><td>26</td></tr><tr><td> </td><td>Married</td><td>111</td></tr>... | <table><tr><td></td><td></td><td>Value</td></tr><tr><td>Age (years)</td><td></td><td>41 (18–79)</td></tr><tr><td>Gender (n)</td><td>Male</td><td>64</td></tr><tr><td></td><td>Female</td><td>73</td></tr><tr><td>Marital status (n)</td><td>Single</td><td>26</td></tr><tr><td></td><td>Married</td><td>111</td></tr><tr><td>Edu... | <table><tr><td></td><td>Value</td></tr><tr><td>University</td><td>20</td></tr></table> |
f6f862563b1c5cb497cfa84a859f4b02fe4a00bd568182c50d3dff7cf22ee8f9.png | simple | <table><tr><td>Feature</td><td>B</td><td>W</td><td>A</td><td>W+A</td><td>LLQ (pg/mL)</td><td>ULQ (pg/mL)</td></tr><tr><td>AR</td><td>73</td><td>27</td><td>0</td><td>27</td><td>48</td><td>5599</td></tr><tr><td>BDNF</td><td>8</td><td>87</td><td>5</td><td>92</td><td>26</td><td>3956</td></tr><tr><td>Flt3Lig</td><td>2</td><... | <table><tr><td>Feature</td><td>B</td><td>W</td><td>A</td><td>W+A</td><td>LLQ (pg/mL)</td><td>ULQ (pg/mL)</td></tr><tr><td>AR</td><td>73</td><td>27</td><td>0</td><td>27</td><td>48</td><td>5599</td></tr><tr><td>BDNF</td><td>8</td><td>87</td><td>5</td><td>92</td><td>26</td><td>3956</td></tr><tr><td>Flt3Lig</td><td>2</td><... | <table><tr><td>Feature</td><td>B</td><td>W</td><td>A</td><td>W+A</td><td>LLQ (pg/mL)</td><td>ULQ (pg/mL)</td></tr><tr><td>GCP-2</td><td>26</td><td>74</td><td>0</td><td>74</td><td>132</td><td>13153</td></tr><tr><td>HCC4</td><td>8</td><td>46</td><td>46</td><td>92</td><td>112</td><td>7907</td></tr><tr><td>I-309</td><td>30... |
da8f2a49e758c9b02e97521ef9374f39c928506713244092a9c1e07ef898cb91.png | complex | <table><tr><td rowspan="3">Antimicrobial Agent</td><td colspan="2">Number (%) of <i>E. coli</i> Isolates</td><td rowspan="3">Test of Independence<i>p</i>-Value *</td></tr><tr><td>Adults</td><td>Young Children</td></tr><tr><td><i>n</i> = 296</td><td><i>n</i> = 86</td></tr><tr><td>Ampicillin</td><td>113 (38.2)</td><td>27... | <table><tr><td rowspan="3">Antimicrobial Agent</td><td colspan="2">Number (%) of E. coli Isolates</td><td rowspan="3">Test of Independencep-Value *</td></tr><tr><td>Adults</td><td>Young Children</td></tr><tr><td>n = 296</td><td>n = 86</td></tr><tr><td>Ampicillin</td><td>113 (38.2)</td><td>27 (31.4)</td><td>0.2506</td><... | <table><tr><td rowspan="3">Antimicrobial Agent</td><td colspan="2">Number (%) of E. coli Isolates</td><td rowspan="3">Test of Independencep-Value *</td></tr><tr><td>Adults</td><td>Young Children</td></tr><tr><td>n = 296</td><td>n = 86</td></tr><tr><td>Tetracycline</td><td>63 (21.3)</td><td>17 (19.8)</td><td>0.7610</td>... |
761f9a5b08d3f31568538a3cfda133772b7e43c62a40e6a4fc26180e569d833d.png | complex | <table><tr><td>Qualitative Theme</td><td>Exemplar Quotation(s)</td></tr><tr><td colspan="2">Less Willing to Honestly Disclose SU/MH with PROs</td></tr><tr><td> Harder to disclose to computer</td><td>“It takes a lot for a person to express how they feel when you can be face to face with somebody. Emotionally and p... | <table><tr><td>Qualitative Theme</td><td>Exemplar Quotation(s)</td></tr><tr><td colspan="2">Less Willing to Honestly Disclose SU/MH with PROs</td></tr><tr><td>Harder to disclose to computer</td><td>“It takes a lot for a person to express how they feel when you can be face to face with somebody. Emotionally and physical... | <table><tr><td>Qualitative Theme</td><td>Exemplar Quotation(s)</td></tr><tr><td colspan="2">More Willing to Honestly Disclose SU/MH with PROs</td></tr><tr><td>Easier to disclose to computer</td><td>“That would give the doctor herself an extra little something that well, I can read this and maybe they don’t want to open... |
6275e20c9d358655d303db991c68302863937d1c43c25e8cc5539a5e4bf4f188.png | simple | <table><tr><td>Modification</td><td>Role</td><td>Species/System</td><td>Region/Residue(s) </td><td>Enzyme</td><td>Reference(s)</td></tr><tr><td>Ubiquitination</td><td>Target for proteasome dependent degradation</td><td>Human Mcm10(HeLa, U2OS)in vivo</td><td>440–525783–803843–875(regions that can media... | <table><tr><td>Modification</td><td>Role</td><td>Species/System</td><td>Region/Residue(s)</td><td>Enzyme</td><td>Reference(s)</td></tr><tr><td>Ubiquitination</td><td>Target for proteasome dependent degradation</td><td>Human Mcm10(HeLa, U2OS)in vivo</td><td>440–525783–803843–875(regions that can mediate degradation)</td... | <table><tr><td>Phosphorylation</td><td>Replisome stability</td><td>Xenopus extract</td><td>S154, S173, S206, S596, S630, S690, S693</td><td>S-CDK</td><td>[113]</td></tr><tr><td>Acetylation</td><td>Protein stability and DNA binding</td><td>Human Mcm10</td><td>K267, K312 *, K318, K390 *, K657, K664, K668, K674 *, K681 *,... |
a52da057c6c05602a07657c68ceb310ca716e93737217240e8da3c31caed5322.png | simple | <table><tr><td></td><td>Group</td><td>n =</td><td>Mean</td><td>Std dev.</td><td>Difference in means MT-AR (95% CI)</td><td>p</td></tr><tr><td>VAS</td><td>AR</td><td>19</td><td>3.3</td><td>26.3</td><td>15.0 (-1.1,31.2)</td><td>.067</td></tr><tr><td></td><td>MT</td><td>20</td><td>18.3</td><td>23.5</td><td></td><td></td><... | <table><tr><td></td><td>Group</td><td>n =</td></tr><tr><td>VAS</td><td>AR</td><td>19</td></tr><tr><td></td><td>MT</td><td>20</td></tr><tr><td>RMQ</td><td>AR</td><td>19</td></tr><tr><td></td><td>MT</td><td>20</td></tr><tr><td>PRI</td><td>AR</td><td>19</td></tr><tr><td></td><td>MT</td><td>20</td></tr></table> | <table><tr><td>Mean</td><td>Std dev.</td><td>Difference in means MT-AR (95% CI)</td><td>p</td></tr><tr><td>3.3</td><td>26.3</td><td>15.0 (-1.1,31.2)</td><td>.067</td></tr><tr><td>18.3</td><td>23.5</td><td></td><td></td></tr><tr><td>0.6</td><td>3.2</td><td>3.6 (1.1,6.2)</td><td>.006</td></tr><tr><td>4.2</td><td>4.5</td>... |
caa031c25086c8ad1572f36d39dba2efba58b74a2817f4b55c2a10d73d0283e0.png | simple | <table><tr><td>Risser’s stage</td><td>Original method</td><td>French method</td></tr><tr><td>Stage 0</td><td>Micro-ossification (2)<sup>1</sup> Gas shadow (1)<sup>2</sup></td><td>Micro-ossification (2)<sup>1</sup> Gas shadow (1)<sup>2</sup></td></tr><tr><td>Stage 1</td><td>Skip ossification (2)<sup>3</sup> Gas sh... | <table><tr><td>Risser’s stage</td></tr><tr><td>Stage 0</td></tr><tr><td>Stage 1</td></tr><tr><td>Stage 2</td></tr><tr><td>Stage 3</td></tr><tr><td>Stage 4</td></tr><tr><td>Stage 5</td></tr></table> | <table><tr><td>Original method</td><td>French method</td></tr><tr><td>Micro-ossification (2)1 Gas shadow (1)2</td><td>Micro-ossification (2)1 Gas shadow (1)2</td></tr><tr><td>Skip ossification (2)3 Gas shadow (1)2</td><td>Gas shadow (1)2 Skip ossification (2)3</td></tr><tr><td>Skip ossification (1)3 Miscalculation of e... |
fb55a2347e03c80c40e81377863ab1465a7ac899dcad76e6119c132947952e82.png | complex | <table><tr><td> </td><td colspan="2">Skin to calyx distance</td><td> </td></tr><tr><td> </td><td colspan="3"></td></tr><tr><td> </td><td>≤75mm</td><td>>75mm</td><td>P value</td></tr><tr><td>Number</td><td>140</td><td>130</td><td> </td></tr><tr><td>Gender</td><td> </td><td> </td><td>0.823</td></tr><tr><td>Male<... | <table><tr><td></td><td colspan="2">Skin to calyx distance</td></tr><tr><td></td><td colspan="2"></td></tr><tr><td></td><td>≤75mm</td><td>>75mm</td></tr><tr><td>Number</td><td>140</td><td>130</td></tr><tr><td>Gender</td><td></td><td></td></tr><tr><td>Male</td><td>88</td><td>80</td></tr><tr><td>Female</td><td>52</td><td... | <table><tr><td></td></tr><tr><td></td></tr><tr><td>P value</td></tr><tr><td></td></tr><tr><td>0.823</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>0.129</td></tr><tr><td>0.090</td></tr><tr><td>0.143</td></tr><tr><td>0.077</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></t... |
1f8c544e18392812f59a419bc21d075c93a6a927d6d9cd26730348a2fa3230b9.png | complex | <table><tr><td>Test set</td><td colspan="3">Our representation</td><td colspan="3">Shen's representation</td></tr><tr><td></td><td>SN (%)</td><td>SP (%)</td><td>AC (%)</td><td>SN (%)</td><td>SP (%)</td><td>AC (%)</td></tr><tr><td>1</td><td>86.5</td><td>88.5</td><td>87.5</td><td>69.2</td><td>84.6</td><td>76.9</td></tr><... | <table><tr><td>Test set</td><td colspan="3">Our representation</td><td colspan="3">Shen's representation</td></tr><tr><td></td><td>SN (%)</td><td>SP (%)</td><td>AC (%)</td><td>SN (%)</td><td>SP (%)</td><td>AC (%)</td></tr><tr><td>1</td><td>86.5</td><td>88.5</td><td>87.5</td><td>69.2</td><td>84.6</td><td>76.9</td></tr><... | <table><tr><td>Test set</td><td colspan="3">Our representation</td><td colspan="3">Shen's representation</td></tr><tr><td></td><td>SN (%)</td><td>SP (%)</td><td>AC (%)</td><td>SN (%)</td><td>SP (%)</td><td>AC (%)</td></tr><tr><td>3</td><td>76.9</td><td>86.5</td><td>81.7</td><td>78.8</td><td>82.7</td><td>80.8</td></tr><... |
74df669bea2b8f5907be8c3a4705cf86835e6d7d5cd39c7f4e2ccfd39c9477c0.png | simple | <table><tr><td>Characteristic</td><td>Improvisation</td><td>Composition</td></tr><tr><td>Context</td><td>Public or private</td><td>Private</td></tr><tr><td>Individual/group</td><td>Individual or group</td><td>Individual or group (less frequent)</td></tr><tr><td>Development</td><td>Continuous, linear, real-time act, ext... | <table><tr><td>Characteristic</td><td>Improvisation</td><td>Composition</td></tr><tr><td>Context</td><td>Public or private</td><td>Private</td></tr><tr><td>Individual/group</td><td>Individual or group</td><td>Individual or group (less frequent)</td></tr><tr><td>Development</td><td>Continuous, linear, real-time act, ext... | <table><tr><td>Abilities</td><td>Performing and compositional</td><td>Compositional</td></tr><tr><td>Processes</td><td>Anticipation, use of repertoire, emotive communication, feedback, and flow</td><td>Planning, translating from the sound to graph, idea generation, organization and construction, revision</td></tr><tr><... |
6ce75f347b8ae64b60da97d0e704132427cb57a5aac66fe4d1c3577d01810846.png | simple | <table><tr><td>Comorbidities and outcomes</td><td>Estimate (mean or proportion)</td><td>95% CI</td></tr><tr><td>Number of comorbidities</td><td>7.54</td><td>(7.53-7.55)</td></tr><tr><td>Charlson comorbidity category</td><td> </td><td> </td></tr><tr><td> Low (1–2)</td><td>0.29%</td><td>(0.26%-0.31%)</td></tr><tr><... | <table><tr><td>Comorbidities and outcomes</td><td>Estimate (mean or proportion)</td><td>95% CI</td></tr><tr><td>Number of comorbidities</td><td>7.54</td><td>(7.53-7.55)</td></tr><tr><td>Charlson comorbidity category</td><td></td><td></td></tr><tr><td>Low (1–2)</td><td>0.29%</td><td>(0.26%-0.31%)</td></tr><tr><td>Medium... | <table><tr><td>Inpatient death</td><td>3.15%</td><td>(3.08%-3.23%)</td></tr><tr><td>Inpatient length of stay (days)</td><td>5.22</td><td>(5.20-5.25)</td></tr><tr><td>Inpatient cost (2009 $US)</td><td>$11,313.28</td><td>($11,233.77-$11,329.80)</td></tr></table> |
62eb6c6bf729213ab1c2607944837c79cb679ff48f901da53634655fbcd78230.png | simple | <table><tr><td>Population</td><td>L</td><td><i>h</i></td><td><i>π</i></td><td><i>K</i></td><td><i>Ho</i></td><td><i>He</i></td><td><i>A</i><sub><i>R</i></sub></td><td><i>Fis</i></td><td>M-<i>He</i></td><td>M-<i>Rs</i></td></tr><tr><td>JL</td><td>12</td><td>0.800</td><td>0.07688</td><td>20.7564</td><td>0.600</td><t... | <table><tr><td>Population</td><td>L</td><td>h</td><td>π</td><td>K</td><td>Ho</td><td>He</td><td>AR</td><td>Fis</td><td>M-He</td><td>M-Rs</td></tr><tr><td>JL</td><td>12</td><td>0.800</td><td>0.07688</td><td>20.7564</td><td>0.600</td><td>0.780</td><td>10.275</td><td>0.255</td><td>0.73</td><td>6.27</td></tr><tr><td>HY</td... | <table><tr><td>DB</td><td>8</td><td>0.862</td><td>0.08600</td><td>23.2196</td><td>0.786</td><td>0.832</td><td>8.000</td><td>0.092</td><td>0.68</td><td>5.68</td></tr><tr><td>XJ</td><td>10</td><td>0.807</td><td>0.10219</td><td>27.5919</td><td>0.741</td><td>0.792</td><td>8.262</td><td>0.084</td><td>0.70</td><td>6.20</td><... |
a87362be639f1a115e13667d03515ac4bedbdd37db96b60b2006652ada9bdd7b.png | complex | <table><tr><td rowspan="2">Conditions</td><td>In-the-bag dislocation</td><td>Out-of-the-bag dislocation</td><td>Overall</td></tr><tr><td>Group (<i>n</i> = 209)</td><td>Group (<i>n</i> = 21)</td><td>(<i>n</i> = 230)</td></tr><tr><td>Pseudoexfoliation</td><td>90 (43.1 %)</td><td>1 (4.8 %)</td><td>91 (39.6 %)</td></tr><tr... | <table><tr><td rowspan="2">Conditions</td><td>In-the-bag dislocation</td><td>Out-of-the-bag dislocation</td><td>Overall</td></tr><tr><td>Group (n = 209)</td><td>Group (n = 21)</td><td>(n = 230)</td></tr><tr><td>Pseudoexfoliation</td><td>90 (43.1 %)</td><td>1 (4.8 %)</td><td>91 (39.6 %)</td></tr><tr><td>Eye rubbing or t... | <table><tr><td>Postglaucoma surgery</td><td>6 (2.9 %)</td><td>0 (0.0 %)</td><td>6 (2.6 %)</td></tr><tr><td>Postkeratoplasty</td><td>2 (1.0 %)</td><td>0 (0.0 %)</td><td>2 (0.9 %)</td></tr><tr><td>Operative complications†</td><td>16 (7.7 %)</td><td>5 (23.8 %)</td><td>21 (9.1 %)</td></tr><tr><td>Secondary implantation‡</t... |
409a77416099dddec2900625aaf875bdf6bca5b1d22b806ab2a5acaede02ce0e.png | complex | <table><tr><td>Strains and conditions</td><td>Throughput (Mbp)</td><td colspan="2">Absolute counts</td><td colspan="2">Ratios</td></tr><tr><td> </td><td> </td><td>Reads aligned on reference genome</td><td>Uniquely aligned reads</td><td>Ratio considering DB110 HP as reference (all reads)</td><td>Ratio considering DB110 ... | <table><tr><td>Strains and conditions</td><td>Throughput (Mbp)</td><td colspan="2">Absolute counts</td><td colspan="2">Ratios</td></tr><tr><td></td><td></td><td>Reads aligned on reference genome</td><td>Uniquely aligned reads</td><td>Ratio considering DB110 HP as reference (all reads)</td><td>Ratio considering DB110 HP... | <table><tr><td>TW30 0.1 MPa (TW30 LP)</td><td>479</td><td>13.699.146</td><td>4.517.864</td><td>0.824</td><td>0.77</td></tr></table> |
14711257dfe4fe0f8925f1995031c7150aa21fe0124afdbfd3e3b092b3a41146.png | simple | <table><tr><td>Months</td><td>2 (<i>n</i> = 7)</td><td>8 (<i>n</i> = 9)</td><td>15 (<i>n</i> = 9)</td><td>24 (<i>n</i> = 9)</td></tr><tr><td>Blood Na ± mEq/L</td><td>141.31 ± 1.18</td><td>145.22 ± 1.56</td><td>145.81 ± 2.73</td><td>147.20 ± 1.22*</td></tr><tr><td>Blood K ± mEq/L</td><td>4.... | <table><tr><td>Months</td><td>2 (n = 7)</td><td>8 (n = 9)</td><td>15 (n = 9)</td><td>24 (n = 9)</td></tr><tr><td>Blood Na ± mEq/L</td><td>141.31 ± 1.18</td><td>145.22 ± 1.56</td><td>145.81 ± 2.73</td><td>147.20 ± 1.22*</td></tr></table> | <table><tr><td>Months</td><td>2 (n = 7)</td><td>8 (n = 9)</td><td>15 (n = 9)</td><td>24 (n = 9)</td></tr><tr><td>Blood K ± mEq/L</td><td>4.22 ± 0.13</td><td>5.46 ± 0.37*</td><td>5.42 ± 0.29*</td><td>5.45 ± 0.26*</td></tr><tr><td>UNaV μEq/min</td><td>0.56 ± 0.13</td><td>0.71 ± 0.06*</td><td>0.75 ± 0.05*</td><td>1.49 ± 0... |
8617551206b498d990ff784a944c89f67af738bfd1811499426df6a6179c35a5.png | complex | <table><tr><td>Cost category</td><td>Cost (USD)</td><td>Percentage</td></tr><tr><td colspan="3"><i>Project costs of program implementation:</i></td></tr><tr><td> Support structure</td><td>57,794</td><td>14.2</td></tr><tr><td> Salary</td><td>196,839</td><td>48.3</td></tr><tr><td> Medicine</td><td>144,020</td><td>35.3</t... | <table><tr><td>Cost category</td><td>Cost (USD)</td></tr><tr><td colspan="2">Project costs of program implementation:</td></tr><tr><td>Support structure</td><td>57,794</td></tr><tr><td>Salary</td><td>196,839</td></tr><tr><td>Medicine</td><td>144,020</td></tr><tr><td>Supplies</td><td>9,301</td></tr><tr><td>Total financi... | <table><tr><td>Percentage</td></tr><tr><td>Project costs of program implementation:</td></tr><tr><td>14.2</td></tr><tr><td>48.3</td></tr><tr><td>35.3</td></tr><tr><td>2.3</td></tr><tr><td>100.0</td></tr><tr><td>Estimated unit costs of program implementation:</td></tr><tr><td></td></tr><tr><td></td></tr></table> |
289fca1fa8dffd831d80cf2a4f4a6fbda936bb7cd326d92f3d2598e42c607b6d.png | complex | <table><tr><td>Parameters</td><td>Definitions</td></tr><tr><td>Patient characteristics</td><td>Age, weight, height, body mass index (BMI), medical insurance status and performance status</td></tr><tr><td>Hospitalisation</td><td>LOS (length of hospitalisation post-operation), the procedure performed, diagnosis, operatin... | <table><tr><td>Parameters</td><td>Definitions</td></tr><tr><td>Patient characteristics</td><td>Age, weight, height, body mass index (BMI), medical insurance status and performance status</td></tr><tr><td>Hospitalisation</td><td>LOS (length of hospitalisation post-operation), the procedure performed, diagnosis, operatin... | <table><tr><td> haemorrhage</td><td>drains or based on ultrasonography</td></tr><tr><td>Post-operative thrombosis</td><td>Evidence of blood thrombosis based on ultrasonography</td></tr><tr><td>APACHE II score</td><td>Acute Physiology and Chronic Health Evaluation II</td></tr></table> |
b23591e3870c042b961c95b8095022e368f2ca449aa0b85c96ad0e82411cc0ad.png | complex | <table><tr><td>Risk-factors</td><td>Level</td><td>Categorization</td></tr><tr><td>Herd<sup>1</sup></td><td>1,2,3,4</td><td> </td></tr><tr><td colspan="3">Sow-related factors</td></tr><tr><td rowspan="2">Parity</td><td>Young</td><td>1st parity</td></tr><tr><td>Mature</td><td>2nd-7th parity</td></tr><tr><td rowspan="2">L... | <table><tr><td>Risk-factors</td><td>Level</td><td>Categorization</td></tr><tr><td>Herd1</td><td>1,2,3,4</td><td></td></tr><tr><td colspan="3">Sow-related factors</td></tr><tr><td rowspan="2">Parity</td><td>Young</td><td>1st parity</td></tr><tr><td>Mature</td><td>2nd-7th parity</td></tr><tr><td rowspan="2">Litter size</... | <table><tr><td>Risk-factors</td><td>Level</td><td>Categorization</td></tr><tr><td rowspan="2">Flanks</td><td>Hollow</td><td>Area behind ribs turned inwards</td></tr><tr><td>Normal</td><td>Area behind ribs followed the line of the ribs</td></tr><tr><td rowspan="2">Hair coat</td><td>Rough</td><td>Hair coat appeared dull<... |
7b63e093ba31d8f2a1b8f03d745f2b4ddb17e01f356c4af9c5bf1b0b5d0151e2.png | simple | <table><tr><td>Site of metastases</td><td>PTC-GD</td><td>Euthyroid</td></tr><tr><td>Bone</td><td>2 (6.8%)</td><td>1 (0.4%)</td></tr><tr><td>Lung</td><td>0</td><td>2 (0.8%)</td></tr><tr><td>Bone + lung</td><td>2 (6.8%)</td><td>4 (1.6%)</td></tr><tr><td>Local recurrence + lung</td><td>0</td><td>3 (1.3%)</td></tr><tr><td>... | <table><tr><td>Site of metastases</td><td>PTC-GD</td><td>Euthyroid</td></tr></table> | <table><tr><td>Bone</td><td>2 (6.8%)</td><td>1 (0.4%)</td></tr><tr><td>Lung</td><td>0</td><td>2 (0.8%)</td></tr><tr><td>Bone + lung</td><td>2 (6.8%)</td><td>4 (1.6%)</td></tr><tr><td>Local recurrence + lung</td><td>0</td><td>3 (1.3%)</td></tr><tr><td>Local recurrence + lung + bone</td><td>0</td><td>3 (1.3%)</td></tr><t... |
127fa2e0480ac2258f7053b082ecbefb4e29d4d4b2054a5a542a1475b0f76c5e.png | complex | <table><tr><td>Parameter</td><td>Description</td><td>Baseline cohort (<i>n</i> = 43)</td><td>PD cohort (<i>n</i> = 40)</td></tr><tr><td>Age at sample draw</td><td>Median age (range)</td><td>72 (37–83)</td><td>63 (35–88)</td></tr><tr><td rowspan="4">Adjuvant endocrine therapy (%)</td><td>No</td><td>26 (60)</... | <table><tr><td>Parameter</td><td>Description</td><td>Baseline cohort (n = 43)</td><td>PD cohort (n = 40)</td></tr><tr><td>Age at sample draw</td><td>Median age (range)</td><td>72 (37–83)</td><td>63 (35–88)</td></tr><tr><td rowspan="4">Adjuvant endocrine therapy (%)</td><td>No</td><td>26 (60)</td><td>26 (65)</td></tr><t... | <table><tr><td>Number of previous lines endocrine therapy lines for MBC (%)</td><td>≥3</td><td></td><td>6 (15)</td></tr><tr><td rowspan="3">Endocrine therapy after start (BL cohort) or before PD (PD cohort) (%)</td><td>AI</td><td>30 (70)</td><td>25 (63)</td></tr><tr><td>Tamoxifen</td><td>13 (30)</td><td>7 (17)</td></tr... |
4745f4a86fa6e0cd501481113d03d78e21bd233abcab0c07a897b7324d8cc1f6.png | complex | <table><tr><td rowspan="2">Variable</td><td colspan="3">Cycling (%<i>W</i><sub>max</sub>) (<i>n</i> = 22)</td><td colspan="3">Knee extension (%MVC) (<i>n</i> = 23)</td></tr><tr><td>Baseline</td><td>30%</td><td>60%</td><td>Baseline</td><td>40%</td><td>75%</td></tr><tr><td colspan="7">Systole</td></tr><tr><td> Apical rot... | <table><tr><td rowspan="2">Variable</td><td colspan="3">Cycling (%Wmax) (n = 22)</td><td colspan="3">Knee extension (%MVC) (n = 23)</td></tr><tr><td>Baseline</td><td>30%</td><td>60%</td><td>Baseline</td><td>40%</td><td>75%</td></tr><tr><td colspan="7">Systole</td></tr><tr><td>Apical rot. (°)</td><td>9.40 ± 3.02</td><td... | <table><tr><td colspan="7">Diastole</td></tr><tr><td>Apical rot. velocity (° s−1)</td><td>−63.59 ± 17.05</td><td>−146.60 ± 31.52†</td><td>−204.35 ± 68.77†‡</td><td>−63.21 (25.81)</td><td>−80.15 (47.50)*</td><td>−119.03 (66.78)†‡</td></tr><tr><td>Basal rot. velocity (° s−1)</td><td>41.47 (25.94)</td><td>73.17 (48.76)†</... |
fe4c5dc1a3be5abf90c6b7c8e3b0a892b6a5bbb4d80d9824a091f7bd22fc453c.png | complex | <table><tr><td></td><td colspan="2">Walk Well</td><td colspan="2">Control</td><td colspan="3">Main between group comparison</td></tr><tr><td>Outcomes</td><td>N</td><td>Mean (SD)</td><td>N</td><td>Mean (SD)</td><td>Mean difference at 12-weeks (95 % CI)<sup>a</sup></td><td>p</td><td>ICC</td></tr><tr><td>Primary outcome</... | <table><tr><td></td><td colspan="2">Walk Well</td><td colspan="2">Control</td><td colspan="3">Main between group comparison</td></tr><tr><td>Outcomes</td><td>N</td><td>Mean (SD)</td><td>N</td><td>Mean (SD)</td><td>Mean difference at 12-weeks (95 % CI)a</td><td>p</td><td>ICC</td></tr><tr><td>Primary outcome</td><td></td... | <table><tr><td></td><td colspan="2">Walk Well</td><td colspan="2">Control</td><td colspan="3">Main between group comparison</td></tr><tr><td>Outcomes</td><td>N</td><td>Mean (SD)</td><td>N</td><td>Mean (SD)</td><td>Mean difference at 12-weeks (95 % CI)a</td><td>p</td><td>ICC</td></tr><tr><td>Step count per day</td><td>4... |
b07a4341b49d449e15d699439590adf40ad65a6b96de4de1f274122dbc13ceca.png | complex | <table><tr><td rowspan="2" colspan="2"></td><td colspan="3">Measures to stockpile</td><td rowspan="2">Total</td></tr><tr><td>Yes</td><td>No</td><td>Don't know</td></tr><tr><td rowspan="3">Hospital size</td><td><100</td><td>1 (12.5 %)</td><td>5 (62.5 %)</td><td>2 (25.0 %)</td><td>8 (100.0 %)</td></tr><tr><td>100-199<... | <table><tr><td rowspan="2" colspan="2"></td><td colspan="3">Measures to stockpile</td><td rowspan="2">Total</td></tr><tr><td>Yes</td><td>No</td><td>Don't know</td></tr><tr><td rowspan="3">Hospital size</td><td><100</td><td>1 (12.5 %)</td><td>5 (62.5 %)</td><td>2 (25.0 %)</td><td>8 (100.0 %)</td></tr><tr><td>100-199</td... | <table><tr><td colspan="2">Total</td><td>23 (51.1 %)</td><td>19 (42.2 %)</td><td>3 (6.7 %)</td><td>45 (100.0 %)</td></tr></table> |
cf41c70b1789b61e3fd6914b4ade6a89b5aecef72d01413027ba29ce696e6980.png | complex | <table><tr><td rowspan="2"></td><td colspan="7">Area</td></tr><tr><td>Khagrachari</td><td>Cox’s Bazar</td><td>Bandarban</td><td>Rangamati</td><td>Netrokona</td><td>Total</td><td>Frequency</td></tr><tr><td>A (1,900 bp)</td><td>10</td><td>56</td><td>6</td><td>1</td><td>2</td><td>75</td><td>0.735</td></tr><tr><td>B ... | <table><tr><td rowspan="2"></td><td colspan="7">Area</td></tr><tr><td>Khagrachari</td><td>Cox’s Bazar</td><td>Bandarban</td><td>Rangamati</td><td>Netrokona</td><td>Total</td><td>Frequency</td></tr><tr><td>A (1,900 bp)</td><td>10</td><td>56</td><td>6</td><td>1</td><td>2</td><td>75</td><td>0.735</td></tr><tr><td>B (1,400... | <table><tr><td> (1,100 bp)</td><td></td><td>5</td><td>2</td><td></td><td></td><td>9</td><td>8</td></tr><tr><td>Mixed</td><td>2</td><td>10</td><td>0</td><td>0</td><td>1</td><td>13</td><td>0.127</td></tr></table> |
b423ef3f38e659b00e7e67c71229e8d8665b57eb84af31efb81b7b9755916f76.png | simple | <table><tr><td>No.</td><td>Abbreviated item</td><td>Factor 1</td><td>Factor 2</td><td>Factor 3</td><td>Factor 4</td><td><i>h</i><sup>2</sup></td></tr><tr><td>1</td><td>Abdominal bloating</td><td>0.78</td><td>0.22</td><td>0.10</td><td>0.14</td><td>0.69</td></tr><tr><td>2</td><td>Tenesmus</td><td>0.74</td><td>0.21</td><t... | <table><tr><td>No.</td><td>Abbreviated item</td><td>Factor 1</td><td>Factor 2</td><td>Factor 3</td><td>Factor 4</td></tr><tr><td>1</td><td>Abdominal bloating</td><td>0.78</td><td>0.22</td><td>0.10</td><td>0.14</td></tr><tr><td>2</td><td>Tenesmus</td><td>0.74</td><td>0.21</td><td>–0.00</td><td>0.12</td></tr><tr><td>3</t... | <table><tr><td>h2</td></tr><tr><td>0.69</td></tr><tr><td>0.61</td></tr><tr><td>0.65</td></tr><tr><td>0.65</td></tr><tr><td>0.66</td></tr><tr><td>0.73</td></tr><tr><td>0.73</td></tr><tr><td>0.71</td></tr><tr><td>0.76</td></tr><tr><td>0.70</td></tr><tr><td>0.75</td></tr><tr><td>0.84</td></tr><tr><td>0.74</td></tr><tr><td... |
e29d7d499456dd42d885c651be695baa727c68b2a368d718938cea8bef432986.png | simple | <table><tr><td></td><td>Mean</td><td>95% HPD</td><td>Posterior probability</td></tr><tr><td>PB2</td><td>August 2016</td><td>June – October 2016</td><td>0.9992</td></tr><tr><td>PB1</td><td>August 2016</td><td>July – October 2016</td><td>0.9993</td></tr><tr><td>PA</td><td>July 2016</td><td>May – October... | <table><tr><td></td><td>Mean</td><td>95% HPD</td><td>Posterior probability</td></tr><tr><td>PB2</td><td>August 2016</td><td>June – October 2016</td><td>0.9992</td></tr></table> | <table><tr><td></td><td>Mean</td><td>95% HPD</td><td>Posterior probability</td></tr><tr><td>PB1</td><td>August 2016</td><td>July – October 2016</td><td>0.9993</td></tr><tr><td>PA</td><td>July 2016</td><td>May – October 2016</td><td>0.9995</td></tr><tr><td>HA</td><td>September 2016</td><td>July – October 2016</td><td>0.... |
a5691d0d73bcb2d28277371d3a0cf5c04a7b0960447791abb3b4a4c239560341.png | complex | <table><tr><td>Accession</td><td>Runs</td><td>0A</td><td>5A</td><td>10A</td><td>15A</td><td>20A</td><td>25A</td></tr><tr><td rowspan="7">SRX016359</td><td>SRR035678</td><td>4,373,013</td><td>4,373,128</td><td>4,373,220</td><td>4,373,338</td><td>4,374,306</td><td>4,840,614</td></tr><tr><td>SRR037439</td><td>2,028,240</t... | <table><tr><td>Accession</td><td>Runs</td><td>0A</td><td>5A</td><td>10A</td><td>15A</td><td>20A</td><td>25A</td></tr><tr><td rowspan="4"></td><td>SRR035678</td><td>4,373,013</td><td>4,373,128</td><td>4,373,220</td><td>4,373,338</td><td>4,374,306</td><td>4,840,614</td></tr><tr><td>SRR037439</td><td>2,028,240</td><td>2,0... | <table><tr><td rowspan="4">SRX016359</td><td>R037441</td><td>,858</td><td>,162,012</td><td>56</td><td>,303</td><td>46</td><td>5,932</td></tr><tr><td>SRR037442</td><td>4,840,368</td><td>4,840,534</td><td>4,840,669</td><td>4,840,802</td><td>4,841,777</td><td>5,319,375</td></tr><tr><td>SRR037443</td><td>2,043,229</td><td>... |
2d5ff5d449790ea738fbed9a1f3e3a6ed9c4d9fa2a59a3675461fe955218eb1b.png | simple | <table><tr><td>Conceptual definition </td><td>Operational definition </td></tr><tr><td>Prostate cancer knowledge—Participants’ understanding of CaP disease, prevention and detection. </td><td>Ten questions assessed participants’ prostate cancer knowledge using a True/False/Don’t Know scale. Each... | <table><tr><td>Conceptual definition</td><td>Operational definition</td></tr><tr><td>Prostate cancer knowledge—Participants’ understanding of CaP disease, prevention and detection.</td><td>Ten questions assessed participants’ prostate cancer knowledge using a True/False/Don’t Know scale. Each correct response had 1 poi... | <table><tr><td>Conceptual definition</td><td>Operational definition</td></tr><tr><td>Decisional conflict—Participants’ state of uncertainty about the course of action to take relative to CaP screening [34].</td><td>O’Connor’s scale [34] provided the items for decisional conflict. The scale used for this study assessed ... |
b4c1925bf57d272f6fa2af977f6f06c677fec5eef2e169baa4ff7a9cae443ed7.png | simple | <table><tr><td>Input</td><td>Processing</td><td>Output</td></tr><tr><td>Alignment</td><td>Export to a different format</td><td>Alignment</td></tr><tr><td>Alignment</td><td>Remove sequences >80 % identical and columns with conservation <0.9</td><td>Alignment</td></tr><tr><td>Alignment</td><td>Construct neighbour-j... | <table><tr><td>Input</td><td>Processing</td><td>Output</td></tr><tr><td>Alignment</td><td>Export to a different format</td><td>Alignment</td></tr><tr><td>Alignment</td><td>Remove sequences >80 % identical and columns with conservation <0.9</td><td>Alignment</td></tr><tr><td>Alignment</td><td>Construct neighbour-joining... | <table><tr><td>Alignment</td><td>Apply bootstrap analysis</td><td>Bootstrap trees</td></tr></table> |
b33d9b98a18cdb40f54ab82765036c67be0a9f38e49d2e653e05b115c45fa585.png | complex | <table><tr><td>Source</td><td>Country</td><td>Filling (Years)</td><td>Remarks</td></tr><tr><td>R Franceys, et al. [15]</td><td>Various</td><td>15–25</td><td>Design recommendations for household properties</td></tr><tr><td>J Pickford [17]</td><td>East Africa</td><td>Over 30</td><td>Reported at a house hold level</... | <table><tr><td>Source</td><td>Country</td><td>Filling (Years)</td><td>Remarks</td></tr><tr><td>R Franceys, et al. [15]</td><td>Various</td><td>15–25</td><td>Design recommendations for household properties</td></tr><tr><td>J Pickford [17]</td><td>East Africa</td><td>Over 30</td><td>Reported at a house hold level</td></t... | <table><tr><td>Source</td><td>Country</td><td>Filling (Years)</td><td>Remarks</td></tr><tr><td>RN Kulabako, et al. [108]</td><td>Uganda</td><td><1</td><td>Low laying areas of peri-urban settlements in Kampala</td></tr><tr><td rowspan="3">K Adubofour, et al. [109]</td><td rowspan="3">Ghana (slums in Kusami metroplis)</t... |
b7a8f81b17902be331edb003ecfff944a29417bb29091398c5d108dc159486fa.png | complex | <table><tr><td colspan="4">MONITORING LAYER</td><td rowspan="3">INFORMATION LAYER</td><td rowspan="3">INTERCHANGE LAYER</td></tr><tr><td colspan="2">Capture Subsystem</td><td rowspan="2">Analysis Subsystem</td><td rowspan="2"><i>Visualization & Control Subsystem</i></td></tr><tr><td>MDP</td><td>Probes</td></tr><tr>... | <table><tr><td colspan="4">MONITORING LAYER</td><td>INFORMATION LAYER</td><td>INTERCHANGE LAYER</td></tr></table> | <table><tr><td colspan="2">Capture Subsystem</td><td rowspan="2">Analysis Subsystem</td><td rowspan="2">Visualization & Control Subsystem</td><td rowspan="2">INFORMATION LAYER</td><td rowspan="2">INTERCHANGE LAYER</td></tr><tr><td>MDP</td><td>Probes</td></tr><tr><td>Communication events:</td><td rowspan="2">Composite p... |
947e0685766e54da74253ecaa62e1e612423291c9fb677aae327aa5a539e44ae.png | simple | <table><tr><td>Locus</td><td>Locus reference</td><td>Number of individuals genotyped in study population</td><td>Predicted allele size</td><td>Observed allele size range</td><td>Number of alleles obs.</td><td>H<sub>e</sub></td><td>H<sub>o</sub></td><td>Est. null allele freq. (CERVUS v3.0)</td><td>Mean estimated error r... | <table><tr><td>Locus</td><td>Locus reference</td></tr><tr><td>ZF01-020</td><td>This study</td></tr><tr><td>ZF01-025</td><td>This study</td></tr><tr><td>TG01-040</td><td>This study</td></tr><tr><td>ZF01-054a</td><td>This study</td></tr><tr><td>ZF01-139b</td><td>This study</td></tr><tr><td>ZF01-136</td><td>This study</td... | <table><tr><td>Number of individuals genotyped in study population</td><td>Predicted allele size</td><td>Observed allele size range</td><td>Number of alleles obs.</td><td>He</td><td>Ho</td><td>Est. null allele freq. (CERVUS v3.0)</td><td>Mean estimated error rate (CERVUS v3.0)</td><td>Multiplex set</td></tr><tr><td>320... |
1e757b99bc576bccba701bc4b7b60ad7870998aefd8211419651bca55e965f9c.png | simple | <table><tr><td>Poroscientific Model 740</td><td>Relative uncertainty (<i>k</i> = 1)</td><td>Absolute uncertainty</td><td>Percent contribution</td><td>Comments</td></tr><tr><td>LP CFV stagnation pres., <i>P</i><sub>0</sub> = 570.03 kPa</td><td>(× 10<sup>−6</sup>)</td><td>(Pa)</td><td>(%)</td><td></td></tr><tr... | <table><tr><td>Poroscientific Model 740</td><td>Relative uncertainty (k = 1)</td><td>Absolute uncertainty</td><td>Percent contribution</td><td>Comments</td></tr><tr><td>LP CFV stagnation pres., P0 = 570.03 kPa</td><td>(× 10−6)</td><td>(Pa)</td><td>(%)</td><td></td></tr><tr><td>Calibration transfer standard for static p... | <table><tr><td>Poroscientific Model 740</td><td>Relative uncertainty (k = 1)</td><td>Absolute uncertainty</td><td>Percent contribution</td></tr><tr><td>LP CFV stagnation pres., P0 = 570.03 kPa</td><td>(× 10−6)</td><td>(Pa)</td><td>(%)</td></tr><tr><td>RSS</td><td>118</td><td>67.5</td><td>100</td></tr></table> |
b0c0dbaf93d45e47df87cc302be9ffd013c966c41c7152f731735017fcf259b5.png | complex | <table><tr><td colspan="5">Quartiles of DDS</td></tr><tr><td></td><td>1st (n = 37)</td><td>2nd (n = 34)</td><td>3rd (n = 46)</td><td>4th (n = 43)</td></tr><tr><td>FSG (mg/dl)</td><td>93.73 ± 12.40</td><td>88.00 ± 12.11</td><td>87.83 ± 13.90</td><td>90.55 ± 16.51</td></tr><tr><td>TG (mg/dl)</td><td>2... | <table><tr><td colspan="5">Quartiles of DDS</td></tr><tr><td></td><td>1st (n = 37)</td><td>2nd (n = 34)</td><td>3rd (n = 46)</td><td>4th (n = 43)</td></tr><tr><td>FSG (mg/dl)</td><td>93.73 ± 12.40</td><td>88.00 ± 12.11</td><td>87.83 ± 13.90</td><td>90.55 ± 16.51</td></tr><tr><td>TG (mg/dl)</td><td>200.47 ± 104.85 a</td... | <table><tr><td colspan="5">Quartiles of DDS</td></tr><tr><td></td><td>1st (n = 37)</td><td>2nd (n = 34)</td><td>3rd (n = 46)</td><td>4th (n = 43)</td></tr><tr><td>Adiponectin (ng/ml)</td><td>11.82 ± 4.35 a</td><td>14.50 ± 4.12</td><td>14.27 ± 3.70</td><td>15.27 ± 5.72</td></tr></table> |
2280b4abc19b850f972dbf35776a5a6301c475463fb4ee40554d70d593ddf7e1.png | simple | <table><tr><td>Bacteria</td><td>Total (<i>N</i> = 221)</td></tr><tr><td>Gram-negative organisms</td><td> </td></tr><tr><td> <i>Klebsiella</i> species</td><td>83 (38%)</td></tr><tr><td> <i>Escherichia coli</i></td><td>72 (33%)</td></tr><tr><td> <i>Pseudomonas aeruginosa</i></td><td>10 (5%)</td></tr><tr><td> <i>Enterobac... | <table><tr><td>Bacteria</td></tr><tr><td>Gram-negative organisms</td></tr><tr><td>Klebsiella species</td></tr><tr><td>Escherichia coli</td></tr><tr><td>Pseudomonas aeruginosa</td></tr><tr><td>Enterobacter species</td></tr><tr><td>Proteus species</td></tr><tr><td>Citrobacter species</td></tr><tr><td>Serratia species</td... | <table><tr><td>Total (N = 221)</td></tr><tr><td></td></tr><tr><td>83 (38%)</td></tr><tr><td>72 (33%)</td></tr><tr><td>10 (5%)</td></tr><tr><td>8 (4%)</td></tr><tr><td>3 (1%)</td></tr><tr><td>3 (1%)</td></tr><tr><td>1 (1%)</td></tr><tr><td>1 (1%)</td></tr><tr><td></td></tr><tr><td>18 (8%)</td></tr><tr><td>17 (8%)</td></... |
bd45d7036ad6b91d2dd60f4eb9f1cfc430aa520cc59c71f6f3524b0cf9e71698.png | complex | <table><tr><td rowspan="2"><i>Level</i></td><td colspan="3"><i>2005–2007</i></td><td colspan="3"><i>2002–2004</i></td></tr><tr><td><i>Total deaths</i></td><td><i>HT deaths</i></td><td><i>%</i></td><td><i>Total deaths</i></td><td><i>HT deaths</i></td><td><i>%</i></td></tr><tr><td>Level 1</td><td>1429</td><td... | <table><tr><td rowspan="2">Level</td><td colspan="3">2005–2007</td><td colspan="2">2002–2004</td></tr><tr><td>Total deaths</td><td>HT deaths</td><td>%</td><td>Total deaths</td><td>HT deaths</td></tr><tr><td>Level 1</td><td>1429</td><td>162</td><td>11.3</td><td>1103</td><td>149</td></tr><tr><td>Level 2</td><td>1527</td>... | <table><tr><td>2002–2004</td></tr><tr><td>%</td></tr><tr><td>13.5</td></tr><tr><td>18.9</td></tr><tr><td>24.8</td></tr></table> |
a9dc2a53337ca3a6ef2bbd318f68a912dc72fd6e9a1111144c2fa36699d96534.png | complex | <table><tr><td></td><td colspan="2">APPLE Schools<sup>a</sup></td><td colspan="2">Alberta Schools<sup>b</sup></td><td colspan="2">Intervention Effect: Change in APPLE Schools over time relative to the coinciding change in Alberta schools (95% CI)<sup>b</sup></td></tr><tr><td>Fruits and vegetables consumption per day (&... | <table><tr><td></td><td colspan="2">APPLE Schoolsa</td><td colspan="2">Alberta Schoolsb</td><td colspan="2">Intervention Effect: Change in APPLE Schools over time relative to the coinciding change in Alberta schools (95% CI)b</td></tr></table> | <table><tr><td>Fruits and vegetables consumption per day (β and 95% CI)</td><td>0.39</td><td>(0.00, 0.78)</td><td>-0.12</td><td>(-0.29, 0.06)</td><td>0.55</td><td>(-0.02, 1.13)</td></tr><tr><td>Dietary energy intake (kcal) per day (β and 95% CI)</td><td>-236.51</td><td>(-366.22, -106.81)</td><td>-25.89</td><td>(-78.34,... |
60e36a943f255bfd49d184f04a8c5a7cfc8a3beac9d5aa300197bd6ef4ca3c59.png | simple | <table><tr><td>Sample<sup>a</sup></td><td>HW Category<sup>b</sup></td><td>Witness® HW</td><td>SNAP® RT</td><td>DiroChek®</td><td>Sample OD(+ control OD) Initial Test</td><td>Sample OD(+ control OD)Post-Heat Treatment</td></tr><tr><td>1</td><td>BL</td><td>+ (+)</td><td>− (vol.<sup>b</sup>)</td><td>+... | <table><tr><td>Samplea</td><td>HW Categoryb</td><td>Witness® HW</td><td>SNAP® RT</td><td>DiroChek®</td><td>Sample OD(+ control OD) Initial Test</td><td>Sample OD(+ control OD)Post-Heat Treatment</td></tr><tr><td>1</td><td>BL</td><td>+ (+)</td><td>− (vol.b)</td><td>+ (+)</td><td>0.038 (0.352)</td><td>0.049 (0.309)</td><... | <table><tr><td>68</td><td>BL</td><td>− (+)</td><td>− (+)</td><td>+ (+)</td><td>0.019 (0.380)</td><td>0.050 (0.309)</td></tr><tr><td>92</td><td>Neg.</td><td>+ (−)</td><td>− (−)</td><td>− (−)</td><td>0.000 (0.380)</td><td>0.000 (0.309)</td></tr><tr><td>98</td><td>BL</td><td>+ (+)</td><td>− (+)</td><td>− (+)</td><td>0.004... |
50c577441c32571ccd8659a3051a541e0dcd78df3057d085d1e0dba54143aea1.png | simple | <table><tr><td>Subscale</td><td>Experimental group (<i>n</i> = 25)</td><td>Control group (<i>n</i> = 23)</td></tr><tr><td>Anxiety</td><td></td><td></td></tr><tr><td> Week 0</td><td>6.3 ± 3.2</td><td>6.5 ± 3.4</td></tr><tr><td> Week 4</td><td>4.1 ± 2.9<sup>∗#</sup></td><td>6.1 ± 3.2</td></tr><t... | <table><tr><td>Subscale</td><td>Experimental group (n = 25)</td><td>Control group (n = 23)</td></tr></table> | <table><tr><td>Anxiety</td><td></td><td></td></tr><tr><td>Week 0</td><td>6.3 ± 3.2</td><td>6.5 ± 3.4</td></tr><tr><td>Week 4</td><td>4.1 ± 2.9∗#</td><td>6.1 ± 3.2</td></tr><tr><td>Depression</td><td></td><td></td></tr><tr><td>Week 0</td><td>4.9 ± 3.8</td><td>4.8 ± 3.1</td></tr><tr><td>Week 4</td><td>3.1 ± 2.8∗∗##</td><... |
0d6cecfb256115a408b5ba7000cfcdc422c95b55e2ebae43fc8ac4db9b425099.png | complex | <table><tr><td>Acceptance Number</td><td>Drug</td><td>Date</td><td>Company</td><td>Progress</td></tr><tr><td>JXSL1600007</td><td rowspan="3">Nivolumab</td><td>17 February 2016</td><td rowspan="3">Bristol-Myers Squibb</td><td rowspan="2">In Assessing</td></tr><tr><td>JXSL1500068</td><td>7 December 2015</td></tr><tr><td>... | <table><tr><td>Acceptance Number</td><td>Drug</td><td>Date</td></tr><tr><td>JXSL1600007</td><td rowspan="3">Nivolumab</td><td>17 February 2016</td></tr><tr><td>JXSL1500068</td><td>7 December 2015</td></tr><tr><td>JXSL1300032</td><td>20 May 2013</td></tr><tr><td>JXSL1600009</td><td rowspan="6">Pembrolizumab</td><td>29 F... | <table><tr><td>Company</td><td>Progress</td></tr><tr><td rowspan="3">Bristol-Myers Squibb</td><td rowspan="2">In Assessing</td></tr><tr></tr><tr><td>In Clinic</td></tr><tr><td rowspan="6">Merck</td><td rowspan="6">In Assessing</td></tr><tr></tr><tr></tr><tr></tr><tr></tr><tr></tr><tr><td>ShangHai JunShi</td><td rowspan... |
bba5b52a46200a69ab634a211bdea601c5af91dee2c2576a793dd5098f9c8da3.png | simple | <table><tr><td>PDB code of the receptor</td><td>AutoDock binding energy (kcal/mol)</td><td>PDB code of the receptor</td><td>AutoDock binding energy (kcal/mol)</td></tr><tr><td>1A8G</td><td>-7.28</td><td>3EKX</td><td>-7.95</td></tr><tr><td>1A9M</td><td>-8.30</td><td>3EM3</td><td>-8.90</td></tr><tr><td>1AJV</td><td>-7.77... | <table><tr><td>PDB code of the receptor</td><td>AutoDock binding energy (kcal/mol)</td></tr><tr><td>1A8G</td><td>-7.28</td></tr><tr><td>1A9M</td><td>-8.30</td></tr><tr><td>1AJV</td><td>-7.77</td></tr><tr><td>1AJX</td><td>-7.24</td></tr><tr><td>1BV9</td><td>-7.38</td></tr><tr><td>1BWA</td><td>-9.25</td></tr><tr><td>1BWB... | <table><tr><td>PDB code of the receptor</td><td>AutoDock binding energy (kcal/mol)</td></tr><tr><td>3EKX</td><td>-7.95</td></tr><tr><td>3EM3</td><td>-8.90</td></tr><tr><td>3MXD</td><td>-7.86</td></tr><tr><td>3MXE</td><td>-7.66</td></tr><tr><td>3NLS</td><td>-8.24</td></tr><tr><td>3O9F</td><td>-8.42</td></tr><tr><td>3O9H... |
248f1d5e615d20a57417f48f0b5fd65c1b78fd35d7edf8590c17f448bce18325.png | simple | <table><tr><td>Inputs</td><td>Outputs</td></tr><tr><td>Solar irradiance spectra</td><td>Radiance spectrum</td></tr><tr><td>Gas absorption and scattering cross sections</td><td>Jacobians (partial derivatives of the radiance spectrum with respect to each of the state vector elements)</td></tr><tr><td>Atmospheric state</t... | <table><tr><td>Inputs</td><td>Outputs</td></tr></table> | <table><tr><td>Solar irradiance spectra</td><td>Radiance spectrum</td></tr><tr><td>Gas absorption and scattering cross sections</td><td>Jacobians (partial derivatives of the radiance spectrum with respect to each of the state vector elements)</td></tr><tr><td>Atmospheric state</td><td>-</td></tr><tr><td>Surface state</... |
dad3a4378100ea7955879023df8dcb145f42ccc069d32f50b593656096228ff5.png | complex | <table><tr><td>Imaging direction</td><td>Treatment</td><td>Sheep (<i>n</i> = 5)</td><td>Pigs (<i>n</i> = 3)</td></tr><tr><td rowspan="4">Dorsal/Ventral</td><td>Baseline</td><td>14</td><td>15</td></tr><tr><td>Hypertonic</td><td>1</td><td>7</td></tr><tr><td>Isotonic</td><td>0</td><td>6</td></tr><tr><td>Mannitol</td><td>0... | <table><tr><td>Imaging direction</td><td>Treatment</td><td>Sheep (n = 5)</td><td>Pigs (n = 3)</td></tr><tr><td rowspan="4">Dorsal/Ventral</td><td>Baseline</td><td>14</td><td>15</td></tr><tr><td>Hypertonic</td><td>1</td><td>7</td></tr><tr><td>Isotonic</td><td>0</td><td>6</td></tr><tr><td>Mannitol</td><td>0</td><td>3</td... | <table><tr><td rowspan="2">Lateral</td><td>Isotonic</td><td>4</td><td>3</td></tr><tr><td>Mannitol</td><td>0</td><td>4</td></tr><tr><td rowspan="3">Other</td><td>Upside down</td><td>2</td><td>0</td></tr><tr><td>At 24 h</td><td>1</td><td>0</td></tr><tr><td>Lung</td><td>0</td><td>4</td></tr><tr><td></td><td></td><td>39</t... |
af86ab6e2aa4481dddcdbbee3134cdcdb9fea0edc3d1146a3bebc69408a1c513.png | complex | <table><tr><td></td><td>Volume (ml)</td><td>Protein concentration (mg/l)</td><td>Specific activity (AU *10000/ml)</td><td>Total activity (AU*100000)</td><td>Recovery (%)</td></tr><tr><td>Culture supernatant</td><td>1000</td><td>1213.64 ± 42.68</td><td>15.36 ± 0.43</td><td>1536</td><td>100</td></tr><tr><td>Sep... | <table><tr><td></td><td>Volume (ml)</td><td>Protein concentration (mg/l)</td><td>Specific activity (AU *10000/ml)</td><td>Total activity (AU*100000)</td><td>Recovery (%)</td></tr></table> | <table><tr><td>Culture supernatant</td><td>1000</td><td>1213.64 ± 42.68</td><td>15.36 ± 0.43</td><td>1536</td><td>100</td></tr><tr><td>Sephadex G-25</td><td>2600</td><td>357.31 ± 17.14</td><td>5.37 ± 0.08</td><td>1397</td><td>90.95</td></tr><tr><td colspan="6">SP FF</td></tr><tr><td>Sepharose</td><td>820</td><td>376.89... |
7c5fb81e4ae61c2dcfc88e16c106dc50a45832752dace0641383160a4c92f7d0.png | complex | <table><tr><td></td><td></td><td colspan="2">Median of Means (Range)</td><td></td><td></td></tr><tr><td>All available data</td><td>No. of comparisons</td><td>TEA group</td><td>GA group</td><td>WMD (95 % CI)</td><td><i>P</i> value</td></tr><tr><td colspan="6">During two-lung ventilation</td></tr><tr><td>PaO<sub>2</sub> ... | <table><tr><td></td><td></td><td>Median of Means (Range)</td></tr><tr><td>All available data</td><td>No. of comparisons</td><td>TEA group</td></tr><tr><td colspan="3">During two-lung ventilation</td></tr><tr><td>PaO2 (mmHg)</td><td>13</td><td>382.42(205.00 to 85.00)</td></tr><tr><td>PaCO2 (mmHg)</td><td>10</td><td>39.6... | <table><tr><td>Median of Means (Range)</td><td></td><td></td></tr><tr><td>GA group</td><td>WMD (95 % CI)</td><td>P value</td></tr><tr><td colspan="3">During two-lung ventilation</td></tr><tr><td>377.92(191.0 to 453.00)</td><td>6.29 [0.04 to 12.17]</td><td>0.35</td></tr><tr><td>40.23 (35.60 to 37.40)</td><td>−0.21 [−1.1... |
1d3945a7bbdaab41c28c56e991c0f1d93f3ed8a38bae27bf9ee69f5519bcacba.png | complex | <table><tr><td>Quintiles of Dietary Intake</td><td>No. Cases</td><td>Person-Years</td><td>Multivariate Adjusted HR (95% CI) <sup>1</sup></td></tr><tr><td colspan="4">Total fiber (g/day)</td></tr><tr><td><10.3</td><td>420</td><td>302,828</td><td>1.00 (Reference)</td></tr><tr><td>10.3–13.6</td><td>426</td><td>31... | <table><tr><td>Quintiles of Dietary Intake</td><td>No. Cases</td><td>Person-Years</td><td>Multivariate Adjusted HR (95% CI) 1</td></tr><tr><td colspan="4">Total fiber (g/day)</td></tr><tr><td><10.3</td><td>420</td><td>302,828</td><td>1.00 (Reference)</td></tr><tr><td>10.3–13.6</td><td>426</td><td>312,546</td><td>1.00 (... | <table><tr><td><1.4</td><td>399</td><td>303,832</td><td>1.00 (Reference)</td></tr><tr><td>1.4–2.0</td><td>397</td><td>313,746</td><td>0.97 (0.84, 1.12)</td></tr><tr><td>2.0–2.6</td><td>379</td><td>316,302</td><td>0.92 (0.79, 1.06)</td></tr><tr><td>2.6–3.5</td><td>396</td><td>318,847</td><td>0.97 (0.83, 1.13)</td></tr><... |
9464465f3d11eb2c0ae7ee9ee31025a79b1a22fa777b8678de6277b4693eb658.png | simple | <table><tr><td>Mycotoxins</td><td>Positives (N)</td><td>Occurrence (%)</td><td>Mean (μg kg<sup>−1</sup>)</td><td>Median (μg kg<sup>−1</sup>)</td><td>Range (μg kg<sup>−1</sup>)</td></tr><tr><td>Raisins</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>TeA</td><td>20</td><td>3... | <table><tr><td>Mycotoxins</td><td>Positives (N)</td><td>Occurrence (%)</td><td>Mean (μg kg−1)</td><td>Median (μg kg−1)</td><td>Range (μg kg−1)</td></tr><tr><td>Raisins</td><td></td><td></td><td></td><td></td><td></td></tr></table> | <table><tr><td>Mycotoxins</td><td>Positives (N)</td><td>Occurrence (%)</td><td>Mean (μg kg−1)</td><td>Median (μg kg−1)</td><td>Range (μg kg−1)</td></tr><tr><td>TeA</td><td>20</td><td>35.1</td><td>104.8</td><td>29.4</td><td>6.9~594.4</td></tr><tr><td>AOH</td><td>3</td><td>5.3</td><td>8.9</td><td>7.5</td><td>3.5~15.6</td... |
60860fbc48b84060f25a21224a45a11e5aa7ab54046e3012178fffde1b04a057.png | simple | <table><tr><td>Subject terms</td><td>Titles</td></tr><tr><td>synuclein</td><td>alpha-synuclein</td></tr><tr><td>alpha synuclein</td><td></td></tr><tr><td>alpha</td><td></td></tr><tr><td>protein</td><td></td></tr><tr><td>aggregation</td><td></td></tr><tr><td>deep brain</td><td>deep brain stimulation</td></tr><tr><td>dee... | <table><tr><td>Subject terms</td><td>Titles</td></tr><tr><td>synuclein</td><td>alpha-synuclein</td></tr><tr><td>alpha synuclein</td><td></td></tr><tr><td>alpha</td><td></td></tr><tr><td>protein</td><td></td></tr><tr><td>aggregation</td><td></td></tr><tr><td>deep brain</td><td>deep brain stimulation</td></tr><tr><td>dee... | <table><tr><td>monoamine oxidase</td><td>monoamine oxidase</td></tr><tr><td>oxidase</td><td></td></tr><tr><td>monoamine</td><td></td></tr><tr><td>mao</td><td></td></tr><tr><td>b</td><td></td></tr><tr><td>mitochondrial</td><td>oxidative stress</td></tr><tr><td>oxidative</td><td></td></tr><tr><td>complex i</td><td></td><... |
09b5ffa2fd874e5d6c5a6e249ce1ade206ce29719d43f0b4d8f22e694e3f7521.png | simple | <table><tr><td>Score</td><td>Criteria</td></tr><tr><td>0</td><td>Active and positive engagement with the assessor or a positive response to the stimuli introduced</td></tr><tr><td>1</td><td>Relaxed or passive response</td></tr><tr><td>2</td><td>Acceptance after a few attempts and eventual tolerance</td></tr><tr><td>3</... | <table><tr><td>Score</td></tr><tr><td>0</td></tr><tr><td>1</td></tr><tr><td>2</td></tr><tr><td>3</td></tr><tr><td>4</td></tr><tr><td>5</td></tr></table> | <table><tr><td>Criteria</td></tr><tr><td>Active and positive engagement with the assessor or a positive response to the stimuli introduced</td></tr><tr><td>Relaxed or passive response</td></tr><tr><td>Acceptance after a few attempts and eventual tolerance</td></tr><tr><td>Overexcitement</td></tr><tr><td>Dog was attempt... |
8f1f625682040379560e14c3aefb4c290f634333403b64add3d5b8dbb76af5c5.png | simple | <table><tr><td>Organisms</td><td>Patients</td></tr><tr><td>Coagulase-negative Staph.</td><td>14 (35%)</td></tr><tr><td>Staph. Aureus`</td><td>7 (17.5%)</td></tr><tr><td>Gram-negative rods</td><td>5 (12.5%)</td></tr><tr><td>Enterococcus</td><td>2 (5%)</td></tr><tr><td>Coliform Bacilli</td><td>3 (7.5%)</td></tr><tr><td>D... | <table><tr><td>Organisms</td><td>Patients</td></tr><tr><td>Coagulase-negative Staph.</td><td>14 (35%)</td></tr><tr><td>Staph. Aureus`</td><td>7 (17.5%)</td></tr><tr><td>Gram-negative rods</td><td>5 (12.5%)</td></tr><tr><td>Enterococcus</td><td>2 (5%)</td></tr><tr><td>Coliform Bacilli</td><td>3 (7.5%)</td></tr><tr><td>D... | <table><tr><td>Organisms</td><td>Patients</td></tr><tr><td>No Pathogens identified</td><td>8 (20%)</td></tr></table> |
e83c5a76607c6d33bd6382cfd0bdb10039e7d3176175558fb38fa42223a85f0e.png | complex | <table><tr><td>Adverse effect</td><td>Outcome</td><td colspan="2">Upper risk limit (%)</td></tr><tr><td></td><td></td><td>Low-dose methylprednisolone</td><td>High-dose methylprednisolone</td></tr><tr><td rowspan="2">Acute severe allergy</td><td>Lethal</td><td>0.24</td><td>0.00<sup>a</sup></td></tr><tr><td>Life-threaten... | <table><tr><td>Adverse effect</td><td>Outcome</td><td colspan="2">Upper risk limit (%)</td></tr><tr><td></td><td></td><td>Low-dose methylprednisolone</td><td>High-dose methylprednisolone</td></tr><tr><td rowspan="2">Acute severe allergy</td><td>Lethal</td><td>0.24</td><td>0.00a</td></tr><tr><td>Life-threatening</td><td... | <table><tr><td>Hepatotoxicity</td><td>Life-threatening</td><td>0.29</td><td>0.66</td></tr><tr><td rowspan="2">Myopathy</td><td>Persistent</td><td>0.46</td><td>0.79</td></tr><tr><td>Life-threatening</td><td>0.07</td><td>0.13</td></tr><tr><td>Osteonecrosisb</td><td>Persistent</td><td>0.57</td><td>1.58</td></tr><tr><td>Pa... |
204aca128b68f985bb2d7f2c37a837bcc7e1667fe206b5284f8309c926a4cf04.png | complex | <table><tr><td rowspan="2">Location</td><td rowspan="2">Year</td><td rowspan="2"><i>N</i></td><td colspan="3">Genotype frequency</td><td>HWE<sup>a</sup></td><td></td></tr><tr><td>Phe/Phe</td><td>Phe/Cys</td><td>Cys/Cys</td><td><i>χ</i><sup>2</sup></td><td><i>P</i></td></tr><tr><td>Porto Velho (RO)</td><td>2010</td... | <table><tr><td rowspan="2">Location</td><td rowspan="2">Year</td><td rowspan="2">N</td><td colspan="3">Genotype frequency</td><td>HWEa</td><td></td></tr><tr><td>Phe/Phe</td><td>Phe/Cys</td><td>Cys/Cys</td><td>χ2</td><td>P</td></tr><tr><td>Porto Velho (RO)</td><td>2010</td><td>37</td><td>0.95</td><td>0.05</td><td>0</td>... | <table><tr><td>Alvorada do Sul (PR)</td><td>2014</td><td>17</td><td>1</td><td>0</td><td>0</td><td>–</td><td>–</td></tr><tr><td>PR</td><td>2009–2014</td><td>118</td><td>0.92</td><td>0.08</td><td>0</td><td>0.185</td><td>0.768</td></tr></table> |
8c9cdc6896b0705a2667fabde76017f50bfceb135a60e49d94154345e979ba8b.png | simple | <table><tr><td>MIGS ID</td><td>Property</td><td>Term</td><td>Evidence code<sup>a</sup></td></tr><tr><td></td><td>Classification</td><td>Domain <i>Bacteria</i></td><td>TAS [7]</td></tr><tr><td></td><td></td><td>Phylum <i>Firmicutes</i></td><td>TAS [8–10]</td></tr><tr><td></td><td></td><td>Class <i>Firmibacteria</i... | <table><tr><td>MIGS ID</td><td>Property</td><td>Term</td><td>Evidence codea</td></tr></table> | <table><tr><td></td><td>Classification</td><td>Domain Bacteria</td><td>TAS [7]</td></tr><tr><td></td><td></td><td>Phylum Firmicutes</td><td>TAS [8–10]</td></tr><tr><td></td><td></td><td>Class Firmibacteria</td><td>TAS [8, 9, 11]</td></tr><tr><td></td><td></td><td>Order Bacillales</td><td>TAS [8, 9, 12, 13]</td></tr><tr... |
e65d6884f0907d132bf076659d3dfe3cb4b0fbf84551fc3ac4993d82368b5c88.png | simple | <table><tr><td>RAFK, RAF-RAFK</td></tr><tr><td>RAFPH, RAFPH-RAF~{p1}</td></tr><tr><td>RAF, MEK-RAF~{p1}, RAF-RAFK, RAFPH-RAF~{p1}, MEK~{p1}-RAF~{p1}, RAF~{p1}</td></tr><tr><td>MEKPH, MEKPH-MEK~{p1}, MEKPH-MEK~{p1, p2}</td></tr><tr><td>MEK, MAPK-MEK~{p1, p2}, MEK-RAF~{p1}, MEKPH-MEK~{p1}, MEKPH-MEK~{p1, p2}, MAPK~{p1}-M... | <table><tr><td>RAFK, RAF-RAFK</td></tr><tr><td>RAFPH, RAFPH-RAF~{p1}</td></tr><tr><td>R</td></tr></table> | <table><tr><td>AF, MEK-RAF~{p1}, RAF-RAFK, RAFPH-RAF~{p1}, MEK~{p1}-RAF~{p1}, RAF~{p1}</td></tr><tr><td>MEKPH, MEKPH-MEK~{p1}, MEKPH-MEK~{p1, p2}</td></tr><tr><td>MEK, MAPK-MEK~{p1, p2}, MEK-RAF~{p1}, MEKPH-MEK~{p1}, MEKPH-MEK~{p1, p2}, MAPK~{p1}-MEK~{p1, p2}, MEK~{p1}-RAF~{p1}, MEK~{p1}, MEK~{p1, p2}</td></tr><tr><td>... |
6609898c396d8cc4db3a67f2673c351ce5f67e28d72487b696ba7cefe8d4954f.png | simple | <table><tr><td>Comparison</td><td></td><td>χ<sup>2</sup> statistics</td><td><i>p</i>-value</td></tr><tr><td>IPI vs. NCCN-IPI</td><td>IPI</td><td>6.46</td><td>0.0110</td></tr><tr><td></td><td>NCCN-IPI</td><td>1.69</td><td>0.1941</td></tr><tr><td>IPI vs. GELTAMO-IPI</td><td>IPI</td><td>10.32</td><td>0.0013</td></tr>... | <table><tr><td>Comparison</td><td></td><td>χ2 statistics</td><td>p-value</td></tr><tr><td>IPI vs. NCCN-IPI</td><td>IPI</td><td>6.46</td><td>0.0110</td></tr><tr><td></td><td>NCCN-IPI</td><td>1.69</td><td>0.1941</td></tr></table> | <table><tr><td>Comparison</td><td></td><td>χ2 statistics</td><td>p-value</td></tr><tr><td>IPI vs. GELTAMO-IPI</td><td>IPI</td><td>10.32</td><td>0.0013</td></tr><tr><td></td><td>GELTAMO-IPI</td><td>3.25</td><td>0.0712</td></tr><tr><td>NCCN-IPI vs. GELTAMO-IPI</td><td>NCCN-IPI</td><td>0.06</td><td>-*</td></tr><tr><td></t... |
7925f0aa29716fb5bae1bbce2d52726c7a225e889c9e9c789bf5c785e9632d40.png | simple | <table><tr><td>Animals</td><td>Saline</td><td>TNBS alone</td><td>TNBS + RTP</td></tr><tr><td>SD rats</td><td>31.5 ± 2.16</td><td>41.8 ± 3.22</td><td>31.9 ± 1.18</td></tr><tr><td>BALB/c mice</td><td>33.7 ± 1.13</td><td>42.9 ± 2.20</td><td>35.1 ± 3.24</td></tr></table> | <table><tr><td>Animals</td></tr><tr><td>SD rats</td></tr><tr><td>BALB/c mice</td></tr></table> | <table><tr><td>Saline</td><td>TNBS alone</td><td>TNBS + RTP</td></tr><tr><td>31.5 ± 2.16</td><td>41.8 ± 3.22</td><td>31.9 ± 1.18</td></tr><tr><td>33.7 ± 1.13</td><td>42.9 ± 2.20</td><td>35.1 ± 3.24</td></tr></table> |
d1ca7174cf470b65761f77d3c54a5b17991aab9f87d19e102a6f8466bf5663d1.png | simple | <table><tr><td>Impact point</td><td><i>P</i><sub>C</sub> (kPa)</td><td><i>P</i><sub>CC</sub> (kPa)</td><td><i>σ</i><sub>VM</sub> (kPa)</td><td><i>τ</i> (kPa)</td></tr><tr><td>A1</td><td>755</td><td>−297</td><td>34.7</td><td>18.8</td></tr><tr><td>A2</td><td>767</td><td>−558</td><td>36.3</td><td>19.... | <table><tr><td>Impact point</td><td>PC (kPa)</td><td>PCC (kPa)</td><td>σVM (kPa)</td><td>τ (kPa)</td></tr><tr><td>A1</td><td>755</td><td>−297</td><td>34.7</td><td>18.8</td></tr><tr><td>A2</td><td>767</td><td>−558</td><td>36.3</td><td>19.4</td></tr><tr><td>A3</td><td>721.7</td><td>−407.7</td><td>36.5</td><td>19.7</td></... | <table><tr><td>B5</td><td>782</td><td>424.6</td><td>37.4</td><td>20.9</td></tr><tr><td>C1</td><td>700</td><td>−338</td><td>34.7</td><td>18.6</td></tr><tr><td>C2</td><td>731</td><td>−362</td><td>35.3</td><td>18.9</td></tr><tr><td>C3</td><td>723.7</td><td>−399</td><td>37</td><td>20.1</td></tr><tr><td>C4</td><td>761</td><... |
dc33e9a845d37f7ed8f98d7098324e17317dad2886eb59142aa05f9132a56ff8.png | complex | <table><tr><td></td><td colspan="4">Fourier Descriptor-Based</td><td colspan="4">GEI-Based</td><td colspan="4">Convexity Defect-Based</td></tr><tr><td>Behavior</td><td>TPR</td><td>PPV</td><td>ACC</td><td>F_Score</td><td>TPR</td><td>PPV</td><td>ACC</td><td>F_Score</td><td>TPR</td><td>PPV</td><td>ACC</td><td>F_Score</td>... | <table><tr><td></td><td colspan="4">Fourier Descriptor-Based</td><td colspan="4">GEI-Based</td><td colspan="4">Convexity Defect-Based</td></tr><tr><td>Behavior</td><td>TPR</td><td>PPV</td><td>ACC</td><td>F_Score</td><td>TPR</td><td>PPV</td><td>ACC</td><td>F_Score</td><td>TPR</td><td>PPV</td><td>ACC</td><td>F_Score</td>... | <table><tr><td></td><td colspan="4">Fourier Descriptor-Based</td><td colspan="4">GEI-Based</td><td colspan="4">Convexity Defect-Based</td></tr><tr><td>Behavior</td><td>TPR</td><td>PPV</td><td>ACC</td><td>F_Score</td><td>TPR</td><td>PPV</td><td>ACC</td><td>F_Score</td><td>TPR</td><td>PPV</td><td>ACC</td><td>F_Score</td>... |
36000c0aaf59fbb2ca3e17c9bc6b2fb5786d1521f350fe710d5a7152553729e2.png | simple | <table><tr><td>IOFB location</td><td>Number of cases (%)</td></tr><tr><td>In the vitreous</td><td>11 (52.38 %)</td></tr><tr><td>In the retina</td><td>7 (33.33 %)</td></tr><tr><td>Perforating</td><td>3 (14.28 %)</td></tr></table> | <table><tr><td>IOFB location</td><td>Number of cases (%)</td></tr><tr><td>In the vitreous</td><td>11 (52.38 %)</td></tr></table> | <table><tr><td>In the retina</td><td>7 (33.33 %)</td></tr><tr><td>Perforating</td><td>3 (14.28 %)</td></tr></table> |
c5608308e640297affa07e148d8b914ee66336ae5601a9a20159edb87e8520fa.png | complex | <table><tr><td>Groups</td><td colspan="4">Time points</td><td>p-value<sup>1</sup></td><td>p-value<sup>2</sup></td></tr><tr><td> </td><td>Baseline n = 87</td><td>4 months n = 76</td><td>8 months n = 74</td><td>12 months* n = 69</td><td> </td><td> </td></tr><tr><td> </td><td colspan="4">MMSE ± SD**</td><td> </td><td... | <table><tr><td>Groups</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>Stimulation therapy</td></tr><tr><td>Donepezil</td></tr><tr><td></td></tr><tr><td>Stimulation therapy</td></tr><tr><td>Donepezil</td></tr><tr><td></td></tr><tr><td>Stimulation therapy</td></tr><tr><td>Donepezil</td></tr></table> | <table><tr><td colspan="4">Time points</td><td>p-value1</td><td>p-value2</td></tr><tr><td>Baseline n = 87</td><td>4 months n = 76</td><td>8 months n = 74</td><td>12 months* n = 69</td><td></td><td></td></tr><tr><td colspan="4">MMSE ± SD**</td><td></td><td></td></tr><tr><td>22.9 ± 4.5</td><td>22.2 ± 5.1</td><td>23.0 ± 4... |
fe758154680912fe75a06c1b44637655ca92594c6f14e136060d47b468f42d63.png | complex | <table><tr><td>Type of interview</td><td>In-depth interviews</td><td>Focus group discussions</td></tr><tr><td colspan="3"><i>Members of HIV serodiscordant couples</i></td></tr><tr><td>N</td><td>42</td><td>25 (total participants – 4FGDs)</td></tr><tr><td>Age, Median (IQR)</td><td>31 (28–38)</td><td>32(28R... | <table><tr><td>Type of interview</td><td>In-depth interviews</td><td>Focus group discussions</td></tr><tr><td colspan="3">Members of HIV serodiscordant couples</td></tr><tr><td>N</td><td>42</td><td>25 (total participants – 4FGDs)</td></tr><tr><td>Age, Median (IQR)</td><td>31 (28–38)</td><td>32(28–35)</td></tr><tr><td>%... | <table><tr><td>Type of interview</td><td>In-depth interviews</td><td>Focus group discussions</td></tr><tr><td>Clinical Officers</td><td colspan="2">2 (10%)</td></tr><tr><td>Safer conception research sites</td><td colspan="2">1</td></tr><tr><td>Public health hospitals</td><td colspan="2">1</td></tr><tr><td>Counsellors</... |
e585ae6518a293ddbf3609ba370810c6de444a8029bf3575bdaa66662a484d65.png | simple | <table><tr><td>Sampling sites</td><td>Functional type</td><td>Vehicle and personnel</td><td>Greenbelt coverage rate</td><td>Air pollution</td></tr><tr><td>SSC</td><td>Shed used to stay chicken waiting for slaughtering</td><td>A few transport vehicles with chickens about 10 times h<sup>−1</sup></td><td>~50%</td><t... | <table><tr><td>Sampling sites</td><td>Functional type</td><td>Vehicle and personnel</td><td>Greenbelt coverage rate</td><td>Air pollution</td></tr><tr><td>SSC</td><td>Shed used to stay chicken waiting for slaughtering</td><td>A few transport vehicles with chickens about 10 times h−1</td><td>~50%</td><td>Serious air pol... | <table><tr><td>Sampling sites</td><td>Functional type</td><td>Vehicle and personnel</td><td>Greenbelt coverage rate</td><td>Air pollution</td></tr><tr><td>V</td><td> personnel and transport vehicles with products</td><td> flow of personnel at commuting time</td><td><5%</td><td>tle air pollution</td></tr><tr><td>GB</td>... |
8ff289859f06f779f727a79e758e48f05d80f52d50b9f4868d04a270b2f0b814.png | simple | <table><tr><td><i>COL4A3</i> polymorphism</td><td>PolyPhen prediction (score)</td><td>SIFT prediction (score)</td></tr><tr><td>G43R</td><td>possibly damaging (1.800)</td><td>not tolerated (0.00)</td></tr><tr><td>P141L</td><td>probably damaging (2.250)</td><td>tolerated (0.40)</td></tr><tr><td>E162G</td><td>benign(0.024... | <table><tr><td>COL4A3 polymorphism</td><td>PolyPhen prediction (score)</td><td>SIFT prediction (score)</td></tr><tr><td>G43R</td><td>possibly damaging (1.800)</td><td>not tolerated (0.00)</td></tr><tr><td>P1</td><td>probably d</td><td>tolera</td></tr></table> | <table><tr><td>41L</td><td>amaging (2.250)</td><td>ted (0.40)</td></tr><tr><td>E162G</td><td>benign(0.024)</td><td>tolerated (0.64)</td></tr><tr><td>D326Y</td><td>probably damaging (2.025)</td><td>tolerated (0.08)</td></tr><tr><td>H451R</td><td>benign (1.426)</td><td>tolerated (0.54)</td></tr><tr><td>P574L</td><td>prob... |
05a6f86abe6bd9937f885d83970676c7f7a041ad37cd2ab8d50e2b4dfb7ca37f.png | complex | <table><tr><td rowspan="2"></td><td rowspan="2">Site</td><td rowspan="2">Amino acid replacements</td><td colspan="5">Aminoacid change</td><td>PAML</td></tr><tr><td>SLAC</td><td>REL</td><td>FEL</td><td>MEME</td><td>FUBAR</td><td>Branch-sites</td></tr><tr><td rowspan="7">COX1</td><td>3</td><td>Y; S (2, 12, 14, 21, 22, 23... | <table><tr><td rowspan="2"></td><td rowspan="2">Site</td><td rowspan="2">Amino acid replacements</td><td colspan="5">Aminoacid change</td><td>PAML</td></tr><tr><td>SLAC</td><td>REL</td><td>FEL</td><td>MEME</td><td>FUBAR</td><td>Branch-sites</td></tr><tr><td rowspan="2">COX1</td><td>3</td><td>Y; S (2, 12, 14, 21, 22, 23... | <table><tr><td rowspan="5">COX1</td><td>199</td><td>G; L (2, 6, 7, 14, 15); V (1); A (5, 10)</td><td>–</td><td>–</td><td>–</td><td>x</td><td>x</td><td>–</td></tr><tr><td>363</td><td>T; S (5, 9, 13, 25)</td><td>–</td><td>–</td><td>–</td><td>x</td><td>–</td><td>–</td></tr><tr><td>365</td><td>V; L (2, 6, 7, 14, 18, 21, 23... |
c9b5eab403e2ce7abdc04cd21790d0b62983fe6f6fcceb2a83d2b01202428b70.png | simple | <table><tr><td>CpG</td><td>A</td><td>B</td><td>V</td><td>Total</td></tr><tr><td>CpG_2</td><td>0.94 (0.93,0.96)</td><td>0.95 (0.93,0.96)</td><td>0.94 (0.92,0.95)</td><td>0.94 (0.93,0.96)</td></tr><tr><td>CpG_3</td><td>0.81 (0.79,0.84)</td><td>0.89 (0.85,0.95)</td><td>0.85 (0.81,0.89)</td><td>0.84 (0.81,0.89)</td></tr><t... | <table><tr><td>CpG</td><td>A</td><td>B</td><td>V</td><td>Total</td></tr><tr><td>CpG_2</td><td>0.94 (0.93,0.96)</td><td>0.95 (0.93,0.96)</td><td>0.94 (0.92,0.95)</td><td>0.94 (0.93,0.96)</td></tr><tr><td>CpG_3</td><td>0.81 (0.79,0.84)</td><td>0.89 (0.85,0.95)</td><td>0.85 (0.81,0.89)</td><td>0.84 (0.81,0.89)</td></tr></... | <table><tr><td>CpG</td><td>A</td><td>B</td><td>V</td><td>Total</td></tr><tr><td>CpG_4</td><td>0.33 (0.06,0.63)</td><td>0.39 (0.18,0.63)</td><td>0.36 (0.25,0.75)</td><td>0.35 (0.04,0.63)</td></tr></table> |
a5fbad1e1831797d45d11bfb9f7672489756c0e6d68302918c5918d31fbcaeb9.png | complex | <table><tr><td rowspan="3"></td><td colspan="4">Model <sup>a</sup></td></tr><tr><td colspan="2">Cr in blood <i>(N = 300)</i></td><td colspan="2">Cr in hair (ln) <i>(N = 299)</i></td></tr><tr><td colspan="2">R<sup>2</sup> = 0.135, (<i>p < 0.001</i>)</td><td colspan="2">R<sup>2</sup> = 0.184, (<i>p < 0.001</i>)</td... | <table><tr><td></td><td colspan="4">Mode</td></tr></table> | <table><tr><td rowspan="3"></td><td colspan="4">l a</td></tr><tr><td colspan="2">Cr in blood (N = 300)</td><td colspan="2">Cr in hair (ln) (N = 299)</td></tr><tr><td colspan="2">R2 = 0.135, (p < 0.001)</td><td colspan="2">R2 = 0.184, (p < 0.001)</td></tr><tr><td>Parameter</td><td>SRC b</td><td>p value</td><td>SRC</td><... |
b82c438897d489e315fd60f6152c35e62657623c29c6f7f125774ff80e98d3af.png | complex | <table><tr><td rowspan="2">S/N</td><td rowspan="2">Communities</td><td colspan="4">Number of health facilities</td><td rowspan="2">Population size (2010 projection)</td><td rowspan="2">Major source of water supply</td><td rowspan="2">Means of waste disposal</td><td rowspan="2">Means of faecal disposal</td></tr><tr><td>... | <table><tr><td rowspan="2">S/N</td><td rowspan="2">Communities</td><td colspan="4">Number of health facilities</td></tr><tr><td>Public</td><td>Private</td><td>Mission</td><td>Other</td></tr><tr><td>1</td><td>Moniya</td><td>6</td><td>4</td><td>0</td><td>0</td></tr><tr><td rowspan="2">2</td><td rowspan="2">Ojoo</td><td r... | <table><tr><td rowspan="2">Population size (2010 projection)</td><td rowspan="2">Major source of water supply</td><td rowspan="2">Means of waste disposal</td><td rowspan="2">Means of faecal disposal</td></tr><tr></tr><tr><td>28,990</td><td>• Well water is the major source</td><td>• Indiscriminate dumping at dump sites ... |
459e4a62f5740f0b056c61ce4573d2ce6029f56da35bcac33fd155c2ee8bc30e.png | complex | <table><tr><td rowspan="2" colspan="2">Assays </td><td colspan="5">Nominal concentration (ng/ml)</td></tr><tr><td>250 </td><td>500 </td><td>1000 </td><td>2000 </td><td>3000 </td></tr><tr><td rowspan="4">Microbiological Intra-assay </td><td>Mean concentration obtained (ng/ml) (<i>n</i>=3) </td><td>345.06 </td><td>600.59... | <table><tr><td rowspan="2" colspan="2">Assays</td><td colspan="5">Nominal concentration (ng/ml)</td></tr><tr><td>250</td><td>500</td><td>1000</td><td>2000</td><td>3000</td></tr><tr><td rowspan="4">Microb</td><td>Mean concentration obtained (ng/ml) (n=3)</td><td>345.06</td><td>600.59</td><td>873.98</td><td>1651.43</td><... | <table><tr><td rowspan="2" colspan="2">Assays</td><td colspan="5">Nominal concentration (ng/ml)</td></tr><tr><td>250</td><td>500</td><td>1000</td><td>2000</td><td>3000</td></tr><tr><td>iological Intra-assay</td><td>curacy</td><td>02</td><td>1</td><td>9</td><td>57</td><td>1</td></tr><tr><td rowspan="4">Microbiological I... |
cb05661dd9b39b20c5526d2db3f4f9b568e85ec3eddfc2c92982ecaa85dd647d.png | complex | <table><tr><td>Predictors of HSCL</td><td>Drop-outs at one- year follow-up N = 155</td><td>Participants at one- year follow-up N = 758</td><td>Drop-outs at 15-year follow-up N = 514</td><td>Participants at 15- year follow-up N = 399</td></tr><tr><td colspan="5"><i>Women:</i></td></tr><tr><td> Age</td><td>-.12</td><td>-... | <table><tr><td>Predictors of HSCL</td><td>Drop-outs at one- year follow-up N = 155</td><td>Participants at one- year follow-up N = 758</td><td>Drop-outs at 15-year follow-up N = 514</td><td>Participants at 15- year follow-up N = 399</td></tr><tr><td colspan="5">Women:</td></tr><tr><td>Age</td><td>-.12</td><td>-.17**</t... | <table><tr><td>Emotional support from friends and family</td><td>-.28**</td><td>-.34**</td><td>-.33**</td><td>-.32**</td></tr><tr><td>Chronic stressors</td><td>.55**</td><td>.54**</td><td>.52**</td><td>.56**</td></tr><tr><td colspan="5">Children:</td></tr><tr><td>Activity</td><td>-.04</td><td>-.05</td><td>-.04</td><td>... |
c6c87ed3181eb4f01cb2df4fb6c98f2a79556ccd0f193eeef4a5f30e6a3cc677.png | simple | <table><tr><td>Reference</td><td><i>n</i></td><td>Subjects/methods</td><td>Exposure Measurement (PC; CC, CS)</td><td>Intervention (RCT)</td><td>Cancer type</td><td>Gene/s</td><td>Locus</td><td>Effect</td></tr><tr><td><i>Al-Hilal et al.</i>, <i>2013</i> [14]</td><td>367</td><td>6-month RCT/M + F, 45–70 year</td><t... | <table><tr><td>Reference</td><td>n</td><td>Subjects/methods</td></tr><tr><td>Al-Hilal et al., 2013 [14]</td><td>367</td><td>6-month RCT/M + F, 45–70 year</td></tr><tr><td>Fradet et al., 2009 [12]</td><td>Control 478; case 466</td><td>CC/M, mean age 65 year</td></tr><tr><td>Gago-Dominguez et al., 2004 [49]</td><td>Contr... | <table><tr><td>Exposure Measurement (PC; CC, CS)</td><td>Intervention (RCT)</td><td>Cancer type</td><td>Gene/s</td><td>Locus</td><td>Effect</td></tr><tr><td></td><td>EPA + DHA; 0.45, 0.9 or 1.9 g/day</td><td></td><td>FADS1 + FADS2</td><td>rs174537</td><td>↓D5D activity associated with T variant allele; ↑D5D activity in... |
7d4a4bf2115e9bf08320b5fcb50fea4d8dabab4a33460b9dc94a4bb80a3dd675.png | simple | <table><tr><td>Instrument A</td><td>Time 1</td><td>Time 2</td><td>Intervention</td><td>Time 3</td><td>Difference score</td><td>Exercise test Result</td></tr><tr><td>Subject 1</td><td>8</td><td>9</td><td>Verum</td><td>15</td><td>+6</td><td>Much improved</td></tr><tr><td>Subject 2</td><td>9</td><td>8</td><td>“̶... | <table><tr><td>Instrument A</td><td>Time 1</td><td>Time 2</td><td>Intervention</td><td>Time 3</td><td>Difference score</td></tr><tr><td>Subject 1</td><td>8</td><td>9</td><td>Verum</td><td>15</td><td>+6</td></tr><tr><td>Subject 2</td><td>9</td><td>8</td><td>“”</td><td>15</td><td>+7</td></tr><tr><td>Subject 3</td><td>8</... | <table><tr><td>Exercise test Result</td></tr><tr><td>Much improved</td></tr><tr><td>Much improved</td></tr><tr><td>Much improved</td></tr><tr><td>Much improved</td></tr><tr><td>Unchanged</td></tr><tr><td>Unchanged</td></tr><tr><td>Unchanged</td></tr><tr><td>Unchanged</td></tr><tr><td>Exercise test Result</td></tr><tr><... |
0611ebfb00e97cf3cede987ecf63545586618cb4b18fa2d448b60be7a335e3e6.png | complex | <table><tr><td>Reference</td><td>Population</td><td><i>N</i></td><td>RRT</td><td>Mortality</td><td>Prognostic factors for hospital mortality</td></tr><tr><td colspan="6">Mixed population (solid and hematological tumors, including bone marrow transplantation)</td></tr><tr><td rowspan="3">Berghmans et al. (15)</td><td>So... | <table><tr><td>Reference</td><td>Population</td><td>N</td><td>RRT</td><td>Mortality</td><td>Prognostic factors for hospital mortality</td></tr><tr><td colspan="6">Mixed population (solid and hematological tumors, including bone marrow transplantation)</td></tr><tr><td rowspan="3">Berghmans et al. (15)</td><td>Solid: 50... | <table><tr><td>Salahudeen et al. (5)</td><td>BMT: 18%</td><td>199</td><td>C-SLED</td><td>Day 30: 65%</td><td>SOFA score, pH, mean blood pressure</td></tr><tr><td colspan="6">Mixed population (solid and hematological tumors, excluding bone marrow transplantation)</td></tr><tr><td rowspan="3">Maccariello et al. (13)</td>... |
dbf450420e0ff336febcc9d72d650cfb801904872c2b13c4af0cd186d20531a9.png | simple | <table><tr><td>OCT (<i>μ</i>m) Mean ± SD</td><td>Chloroquine group</td><td>Control group</td><td><i>p</i> value<sup><i>∗</i></sup></td></tr><tr><td>CFT</td><td>238.15 ± 22.5</td><td>248.2 ± 19.05</td><td>0.034</td></tr><tr><td>Parafoveal thickness</td><td> </td><td> </td><td> </td></tr><tr><td... | <table><tr><td>OCT (μm) Mean ± SD</td><td>Chloroquine group</td><td>Control group</td><td>p value∗</td></tr><tr><td>CFT</td><td>238.15 ± 22.5</td><td>248.2 ± 19.05</td><td>0.034</td></tr><tr><td>Parafoveal thickness</td><td></td><td></td><td></td></tr><tr><td>Superior</td><td>310.7 ± 21.64</td><td>322.35 ± 12.02</td><t... | <table><tr><td>OCT (μm) Mean ± SD</td><td>Chloroquine group</td><td>Control group</td><td>p value∗</td></tr><tr><td>FLV</td><td>0.86 ± 1.04</td><td>0.60 ± 0.53</td><td>0.167</td></tr><tr><td>GLV</td><td>4.28 ± 3.87</td><td>3.56 ± 3.05</td><td>0.358</td></tr></table> |
720ec128431eaa828944965c8cc1c61e204f8c12e2850c62c618c3a3a0f84926.png | simple | <table><tr><td>Metal</td><td>PFP soluble metals (μg metal/g PM)</td><td>Fresno soluble metals (μg metal/g PM)b</td></tr><tr><td>Co</td><td>< 3.2</td><td>n/a</td></tr><tr><td>Cr</td><td>< 0.84</td><td>n/a</td></tr><tr><td>Cu</td><td>< 1.0</td><td>344 ± 137</td></tr><tr><td>Fe</td><td>< 25</td>... | <table><tr><td>Metal</td><td>PFP soluble metals (μg metal/g PM)</td><td>Fresno soluble metals (μg metal/g PM)b</td></tr><tr><td>Co</td><td>< 3.2</td><td>n/a</td></tr><tr><td>Cr</td><td>< 0.84</td><td>n/a</td></tr><tr><td>Cu</td><td>< 1.0</td><td>344 ± 137</td></tr><tr><td>Fe</td><td>< 25</td><td>262 ± 32</td></tr><tr><... | <table><tr><td>V</td><td>.68</td><td> ± 3</td></tr><tr><td>Zn</td><td>7.8 ± 4.9</td><td>n/a</td></tr></table> |
d7e87a3782dd10b498799087bd7a732ef164b01f3e5d8e0dd05f0d8aa217d421.png | simple | <table><tr><td></td><td>Before SVA onset (<i>n</i> = 30)</td><td>After SVA onset (<i>n</i> = 30)</td><td><i>p</i></td></tr><tr><td>Systolic arterial pressure, mmHg</td><td>114 [97–127]</td><td>97 [86–118]</td><td>0.076</td></tr><tr><td>Diastolic arterial pressure, mmHg</td><td>58 [51–63]</td><td>58 [4... | <table><tr><td></td><td>Before SVA onset (n = 30)</td><td>After SVA onset (n = 30)</td><td>p</td></tr><tr><td>Systolic arterial pressure, mmHg</td><td>114 [97–127]</td><td>97 [86–118]</td><td>0.076</td></tr><tr><td>Diastolic arterial pressure, mmHg</td><td>58 [51–63]</td><td>58 [47–64]</td><td>0.513</td></tr><tr><td>Me... | <table><tr><td></td><td>Before SVA onset (n = 30)</td><td>After SVA onset (n = 30)</td><td>p</td></tr><tr><td>Dobutamine dose, μg/kg/mina</td><td>7.5 [5.0–10.0]</td><td>7.5 [5.0–10.0]</td><td>>0.99</td></tr><tr><td>Norepinephrine dose, mg/ha</td><td>1.7 [0.3–3.0]</td><td>1.8 [0.5–4.5]</td><td>0.010</td></tr><tr><td>Epi... |
64dd02bdcca1c0ab817042e93de32b14d0e9ad988a37b0925227068f058871ab.png | complex | <table><tr><td></td><td>Nest (%)</td><td>Environment (%)</td><td>Chi-square</td><td><i>P</i></td></tr><tr><td colspan="5">Egg stage</td></tr><tr><td> String</td><td>55</td><td>76</td><td>3.366</td><td>0.07</td></tr><tr><td> Foil</td><td>10</td><td>13</td><td>0.391</td><td>0.53</td></tr><tr><td> Paper</td><td>0</td><td>... | <table><tr><td></td><td>Nest (%)</td><td>Environment (%)</td><td>Chi-square</td><td>P</td></tr><tr><td colspan="5">Egg stage</td></tr><tr><td>String</td><td>55</td><td>76</td><td>3.366</td><td>0.07</td></tr><tr><td>Foil</td><td>10</td><td>13</td><td>0.391</td><td>0.53</td></tr><tr><td>Paper</td><td>0</td><td>2</td><td>... | <table><tr><td></td><td>Nest (%)</td><td>Environment (%)</td><td>Chi-square</td><td>P</td></tr><tr><td>Foil</td><td>21</td><td>8</td><td>5.828</td><td>0.02</td></tr><tr><td>Paper</td><td>11</td><td>2</td><td>6.231</td><td>0.01</td></tr><tr><td>Other</td><td>38</td><td>7</td><td>21.356</td><td>< 0.001</td></tr></table> |
9030b2f5d0fe3002f25a5d845bc6f6511fb37cf4a7465ae0f5a1d28a6337aebf.png | complex | <table><tr><td></td><td></td><td>Number of clones</td><td>Number of heteroinsertion</td><td>Number of homoinsertion</td><td>Efficiency of heteroinsertion</td><td>Efficiency of homoinsertion</td></tr><tr><td rowspan="2"><i>Eed</i></td><td>LNL insertion</td><td>88</td><td>17</td><td>4</td><td>19.3%</td><td>4.5%</td></tr>... | <table><tr><td></td><td></td><td>Number of clones</td><td>Number of heteroinsertion</td><td>Number of homoinsertion</td><td>Efficiency of heteroinsertion</td><td>Efficiency of homoinsertion</td></tr><tr><td rowspan="2">Eed</td><td>LNL insertion</td><td>88</td><td>17</td><td>4</td><td>19.3%</td><td>4.5%</td></tr><tr><td... | <table><tr><td rowspan="2">SRCAP</td><td>LNL insertion</td><td>94</td><td>65</td><td>3</td><td>69.1%</td><td>3.2%</td></tr><tr><td>FNFL insertion</td><td>96</td><td>70</td><td>2</td><td>72.9%</td><td>2.1%</td></tr></table> |
5f381ad5f092f463421f960c2cea3c67fae4aa6d5f488394e4007380a092622d.png | simple | <table><tr><td>Donor</td><td>Population</td><td>Expansionday</td><td>EGA sample accessionnumber</td></tr><tr><td>1</td><td>IgM<sup>+</sup> IgD<sup>+</sup></td><td>0</td><td>EGAN00001588556</td></tr><tr><td>1</td><td>IgM<sup>+</sup> IgD<sup>-</sup></td><td>0</td><td>EGAN00001588558</td></tr><tr><td>1</td><td>IgM<sup>-</... | <table><tr><td>Donor</td><td>Population</td><td>Expansionday</td><td>EGA sample accessionnumber</td></tr><tr><td>1</td><td>IgM+ IgD+</td><td>0</td><td>EGAN00001588556</td></tr><tr><td>1</td><td>IgM+ IgD-</td><td>0</td><td>EGAN00001588558</td></tr><tr><td>1</td><td>IgM- IgD-</td><td>0</td><td>EGAN00001588559</td></tr><t... | <table><tr><td>2</td><td>IgM+ IgD+</td><td>0</td><td>EGAN00001588549</td></tr><tr><td>2</td><td>IgM+ IgD-</td><td>0</td><td>EGAN00001588541</td></tr><tr><td>2</td><td>IgM- IgD-</td><td>0</td><td>EGAN00001588542;EGAN00001588543</td></tr><tr><td>2</td><td>IgM+ IgD+</td><td>5</td><td>EGAN00001588575</td></tr><tr><td>2</td... |
00fe8dad30865d3249928e5f3000a17171d8c2782b814e7006f4883f324ec649.png | complex | <table><tr><td></td><td>Total (n = 116)</td><td>Covered (n = 42)</td><td>Uncovered (n = 74)</td><td><i>p </i>value¶</td></tr><tr><td colspan="5">Complication rate</td></tr><tr><td> Stent migration, n(%)</td><td>8(6.9)</td><td>4(9.5)</td><td>4(5.4)</td><td>0.458</td></tr><tr><td> Granulation tissue formation, n(%)<... | <table><tr><td></td><td>Total (n = 116)</td><td>Covered (n = 42)</td><td>Uncovered (n = 74)</td></tr><tr><td colspan="4">Complication rate</td></tr><tr><td>Stent migration, n(%)</td><td>8(6.9)</td><td>4(9.5)</td><td>4(5.4)</td></tr><tr><td>Granulation tissue formation, n(%)</td><td>22(19.0)</td><td>7 (16.7)</td><td>15(... | <table><tr><td>p value¶</td></tr><tr><td>Complication rate</td></tr><tr><td>0.458</td></tr><tr><td>0.634</td></tr><tr><td>0.44</td></tr><tr><td>0.363</td></tr></table> |
b1ff56ba9bcdf759d5837e0fca17a22501c6247ab91186cb6fd85d4245c25962.png | simple | <table><tr><td> </td><td>Hazard ratio</td><td>95% CI</td><td>p</td></tr><tr><td>Model 1*</td><td> </td><td> </td><td> </td></tr><tr><td>Age</td><td>1.02</td><td>1.01-1.03</td><td>0.01</td></tr><tr><td>Heart failure</td><td>1.83</td><td>1.18-2.83</td><td>0.007</td></tr><tr><td>Hemoglobin on admission</td><td>0.91</td><t... | <table><tr><td></td><td>Hazard ratio</td><td>95% CI</td><td>p</td></tr><tr><td>Model 1*</td><td></td><td></td><td></td></tr><tr><td>Age</td><td>1.02</td><td>1.01-1.03</td><td>0.01</td></tr><tr><td>Heart failure</td><td>1.83</td><td>1.18-2.83</td><td>0.007</td></tr><tr><td>Hemoglobin on admission</td><td>0.91</td><td>0.... | <table><tr><td></td><td>Hazard ratio</td><td>95% CI</td><td>p</td></tr><tr><td>Model 1 + SAPS II</td><td></td><td></td><td></td></tr><tr><td>Heart failure</td><td>2.25</td><td>1.29-3.93</td><td>0.005</td></tr><tr><td>Coronary artery disease</td><td>0.40</td><td>0.21-0.77</td><td>0.006</td></tr><tr><td>Hemoglobin on adm... |
d81cc0591e527fff90c9f76529feacf21141f23c3723a64526febc83c3470fc6.png | simple | <table><tr><td>Indexes</td><td>Biological Rope Unit</td><td><i>Myriophyllum verticillatum</i> Unit</td><td><i>Iris wilsonii</i> Unit</td><td>Activated Carbon Unit</td></tr><tr><td>TN</td><td>16.07%</td><td>28.10%</td><td>30.33%</td><td>19.55%</td></tr><tr><td>NO<sub>3</sub><sup>−</sup>-N</td><td>28.64%</td><td>37... | <table><tr><td>Indexes</td><td>Biological Rope Unit</td><td>Myriophyllum verticillatum Unit</td><td>Iris wilsonii Unit</td><td>Activated Carbon Unit</td></tr><tr><td>TN</td><td>16.07%</td><td>28.10%</td><td>30.33%</td><td>19.55%</td></tr><tr><td>NO3−-N</td><td>28.64%</td><td>37.02%</td><td>33.78%</td><td>25.03%</td></t... | <table><tr><td>Indexes</td><td>Biological Rope Unit</td><td>Myriophyllum verticillatum Unit</td><td>Iris wilsonii Unit</td><td>Activated Carbon Unit</td></tr><tr><td>NH4+-N</td><td>17.68%</td><td>25.12%</td><td>29.22%</td><td>28.04%</td></tr><tr><td>TP</td><td>21.19%</td><td>3.96%</td><td>6.05%</td><td>4.17%</td></tr><... |
f99321a55f59bf69d2ff5cfe23e739a4a8918fe91426e5e1d230a558f364292c.png | complex | <table><tr><td colspan="4">Characteristics</td></tr><tr><td>Characteristics of the children</td><td></td><td>N</td><td>%</td></tr><tr><td>Age (n = 1067)</td><td>- 2 or 3 years old</td><td>227</td><td>21%</td></tr><tr><td></td><td>- 4 years old</td><td>335</td><td>31%</td></tr><tr><td></td><td>- 5 years old</td><td>328<... | <table><tr><td colspan="4">Characteristics</td></tr><tr><td>Characteristics of the children</td><td></td><td>N</td><td>%</td></tr><tr><td>Age (n = 1067)</td><td>- 2 or 3 years old</td><td>227</td><td>21%</td></tr><tr><td></td><td>- 4 years old</td><td>335</td><td>31%</td></tr><tr><td></td><td>- 5 years old</td><td>328<... | <table><tr><td></td><td>- High school diploma ("Baccalauréat")</td><td>238</td><td>23%</td></tr><tr><td></td><td>- Lower tertiary</td><td>235</td><td>23%</td></tr><tr><td></td><td>- Higher tertiary</td><td>279</td><td>27%</td></tr><tr><td>Annual family income (n = 949)</td><td>- < 14 000 €</td><td>168</td><td>18%</td>... |
e684937ad2d8653876151d3b85379399757e07cb0bf6d3943f4e913d5254e049.png | simple | <table><tr><td>Procedure</td><td>Total volume (mL)</td><td>Total protein (mg)</td><td>Total activity (UI)<sup>a</sup></td><td>Specific activity<sup>b</sup> (UI mg<sup>−1</sup>)</td><td>Purification<sup>c</sup> (fold)</td></tr><tr><td>Crude extract</td><td>300</td><td>1302.3</td><td>215220</td><td>165.3</td><td>1<... | <table><tr><td>Procedure</td><td>Total volume (mL)</td><td>Total protein (mg)</td><td>Total activity (UI)a</td><td>Specific activityb (UI mg−1)</td><td>Purificationc (fold)</td></tr><tr><td>Crude extract</td><td>300</td><td>1302.3</td><td>215220</td><td>165.3</td><td>1</td></tr><tr><td>Ammonium Sulphate ppt.</td><td>22... | <table><tr><td>Procedure</td><td>Total volume (mL)</td><td>Total protein (mg)</td><td>Total activity (UI)a</td><td>Specific activityb (UI mg−1)</td><td>Purificationc (fold)</td></tr><tr><td>Dialysis</td><td>21</td><td>39.2</td><td>12559.9</td><td>320.4</td><td>1.94</td></tr><tr><td>DEAE-cellulose</td><td>12</td><td>6.3... |
276677b6d54c18f49b4465d50abcf3e04a6569ff7fe33152b16074b66d36a870.png | complex | <table><tr><td rowspan="2">Gene name</td><td rowspan="2">Gene symbol</td><td rowspan="2">Comments</td><td colspan="2">Statistics</td></tr><tr><td>Log<sub>2</sub> fold change</td><td><i>q</i> value</td></tr><tr><td>Spermidine synthetase</td><td><i>Srm</i></td><td>Synthesizes polyamines important in granule biogenesis an... | <table><tr><td rowspan="2">Gene name</td><td rowspan="2">Gene symbol</td><td rowspan="2">Comments</td><td colspan="2">Statistics</td></tr><tr><td>Log2 fold change</td><td>q value</td></tr><tr><td>Spermidine synthetase</td><td>Srm</td><td>Synthesizes polyamines important in granule biogenesis and homeostasis, including ... | <table><tr><td>Lysosomal trafficking regulator</td><td>Lyst</td><td>Important regulator of granule formation (Durchfort 2012 [95], Hammel 2010 [52])</td><td>−1.29</td><td>0.00016</td></tr><tr><td>Solute carrier family 18, member 2</td><td>Slc18a2</td><td>Transports histamine and serotonin into granules (Merickel 1995 [... |
2ed7b4620c5b6672c3f5c7f3358e1cc9e4d90c91cb15f9a2fbd8213b583f4064.png | complex | <table><tr><td rowspan="2">Factor</td><td rowspan="2">B</td><td rowspan="2">p-value</td><td rowspan="2">OR</td><td colspan="2">95% CI for OR</td></tr><tr><td>Lower</td><td>Upper</td></tr><tr><td>Age</td><td>.061</td><td>.436</td><td>1.063</td><td>.912</td><td>1.239</td></tr><tr><td>Sex (Female)</td><td>.407</td><td>.48... | <table><tr><td rowspan="2">Factor</td><td rowspan="2">B</td><td rowspan="2">p-value</td><td rowspan="2">OR</td><td colspan="2">95% CI for OR</td></tr><tr><td>Lower</td><td>Upper</td></tr><tr><td>Age</td><td>.061</td><td>.436</td><td>1.063</td><td>.912</td><td>1.239</td></tr><tr><td>Sex (Female)</td><td>.407</td><td>.48... | <table><tr><td>BMI</td><td>.019</td><td>.755</td><td>1.019</td><td>.904</td><td>1.150</td></tr><tr><td>Medications</td><td>-.118</td><td>.425</td><td>.889</td><td>.665</td><td>1.188</td></tr><tr><td>Comorbidities</td><td>.388</td><td>.093</td><td>1.474</td><td>.938</td><td>2.318</td></tr><tr><td>ASA class</td><td>1.667... |
d3e8a42e789a9b37560fd1c22176305b4cd26fb76318857e33cd212d916b6e22.png | simple | <table><tr><td></td><td>Diabetic footpatients</td><td>Diabetics withoutfoot complications</td><td>p</td></tr><tr><td>HbA1c</td><td>8 (7.28-9.40)</td><td>6.85 (6.10-8.00)</td><td>0.018</td></tr><tr><td>CRP</td><td>4 (2.25-5.15)</td><td>2.25 (1.90-3.08)</td><td>0.041</td></tr><tr><td>Total cholesterol (mg/dl)</td><td>215... | <table><tr><td></td><td>Diabetic footpatients</td><td>Diabetics withoutfoot complications</td><td>p</td></tr><tr><td>HbA1c</td><td>8 (7.28-9.40)</td><td>6.85 (6.10-8.00)</td><td>0.018</td></tr><tr><td>CRP</td><td>4 (2.25-5.15)</td><td>2.25 (1.90-3.08)</td><td>0.041</td></tr><tr><td>Total cholesterol (mg/dl)</td><td>215... | <table><tr><td>Resistin (ng/ml)</td><td>5.160 (2.96-6.29)</td><td>3.290 (2.37-6.5)</td><td>0.021</td></tr><tr><td>IL-6 (pg/ml)</td><td>3.21 (1.23-5.34)</td><td>2.13 (1.24-3.97)</td><td>0.033</td></tr></table> |
fc23877a2d63efd4900f24a735f4e4609856bca09895a101fce2b6954863c066.png | simple | <table><tr><td>Histone</td><td>Modification 1</td><td>Modification 2</td><td>Modification 3</td><td>Modification 4</td><td>Intensity average 6xHIS-Ibd1 (4 repetitions)</td><td>Intensity average 6xHIS-G9a (2 repetitions)</td></tr><tr><td>H3</td><td><i>K9ac</i></td><td><i>K14ac</i></td><td></td><td></td><td><i>0.95</i></... | <table><tr><td>Histone</td><td>Modification 1</td><td>Modification 2</td><td>Modification 3</td><td>Modification 4</td><td>Intensity average 6xHIS-Ibd1 (4 repetitions)</td><td>Intensity average 6xHIS-G9a (2 repetitions)</td></tr><tr><td>H3</td><td>K9ac</td><td>K14ac</td><td></td><td></td><td>0.95</td><td>0.02</td></tr>... | <table><tr><td>Histone</td><td>Modification 1</td><td>Modification 2</td><td>Modification 3</td><td>Modification 4</td><td>Intensity average 6xHIS-Ibd1 (4 repetitions)</td><td>Intensity average 6xHIS-G9a (2 repetitions)</td></tr><tr><td>H3</td><td>R2me2a</td><td>K4me3</td><td>R8me2a</td><td>K9me2</td><td>0.18</td><td>0... |
af9d63629b7fc738893b6e75a3a7539f6bccd4b376cf18ff9252cf096e1c2874.png | complex | <table><tr><td>Characteristic</td><td>n</td><td>%</td></tr><tr><td>Area of practice</td><td></td><td></td></tr><tr><td>GP/FP</td><td>117</td><td>27</td></tr><tr><td>GP/FP with enhanced area</td><td>72</td><td>17</td></tr><tr><td>Specialist</td><td>219</td><td>51</td></tr><tr><td>Other<sup>1</sup>:</td><td>6</td><td>1</... | <table><tr><td>Characteristic</td><td>n</td><td>%</td></tr><tr><td>Area of practice</td><td></td><td></td></tr><tr><td>GP/FP</td><td>117</td><td>27</td></tr><tr><td>GP/FP with enhanced area</td><td>72</td><td>17</td></tr><tr><td>Specialist</td><td>219</td><td>51</td></tr><tr><td>Other1:</td><td>6</td><td>1</td></tr><tr... | <table><tr><td>Characteristic</td><td>n</td><td>%</td></tr><tr><td>oth</td><td></td><td></td></tr><tr><td>Not specified</td><td>12</td><td>3</td></tr><tr><td colspan="2">Language of survey completion</td><td></td></tr><tr><td>English</td><td>388</td><td>91</td></tr><tr><td>French</td><td>38</td><td>9</td></tr></table> |
f2238b414473ddbdbdbe34386afcc87d96ea6a9cfafb4ed8dedc4aa82d5b35cb.png | complex | <table><tr><td rowspan="2">Bacteria</td><td colspan="4">MIC (mg/mL)</td></tr><tr><td>IxPE</td><td>IxCE</td><td>IxME</td><td>IxWE</td></tr><tr><td><i>Bacillus subtilis </i>(MTCC111)</td><td>2</td><td>>2</td><td>0.125</td><td>1</td></tr><tr><td><i>Staphylococcus aureus </i>(MTCC3160)</td><td>>2</td><td>>2</td><t... | <table><tr><td rowspan="2">Bacteria</td><td colspan="4">MIC (mg/mL)</td></tr><tr><td>IxPE</td><td>IxCE</td><td>IxME</td><td>IxWE</td></tr><tr><td>Bacillus subtilis (MTCC111)</td><td>2</td><td>>2</td><td>0.125</td><td>1</td></tr><tr><td>Staphylococcus aureus (MTCC3160)</td><td>>2</td><td>>2</td><td>1</td><td>>2</td></tr... | <table><tr><td>Klebsiella pneumoniae (MTCC109)</td><td>>2</td><td>>2</td><td>0.25</td><td>>2</td></tr><tr><td>Pseudomonas aeruginosa (MTCC741)</td><td>2</td><td>2</td><td>0.5</td><td>2</td></tr></table> |
11cb9c18a9babdd9a2d9dc17981242367f7f610b08908c5a76113651434f7f11.png | simple | <table><tr><td></td><td>Current wheeze</td><td>Ever had wheeze</td><td>Wheeze disturb sleep</td><td>Wheeze limiting speech</td><td>Exercise wheeze</td><td>Night cough</td><td>Ever had asthma</td><td>Any asthma symptoms</td></tr><tr><td>Boys</td><td>29 (9.0%)</td><td>75 (25.3%)</td><td>3 (3.8%)</td><td>4 (4.8%)</td><td>... | <table><tr><td></td><td>Current wheeze</td><td>Ever had wheeze</td><td>Wheeze disturb sleep</td><td>Wheeze limiting speech</td><td>Exercise wheeze</td><td>Night cough</td><td>Ever had asthma</td><td>Any asthma symptoms</td></tr><tr><td>Boys</td><td>29 (9.0%)</td><td>75 (25.3%)</td><td>3 (3.8%)</td><td>4 (4.8%)</td><td>... | <table><tr><td>Girls</td><td>22 (5.8%)</td><td>65 (18.5%)</td><td>8 (11.6%)</td><td>4 (5.48%)</td><td>15 (4.3%)</td><td>38 (11.0%)</td><td>31 (8.2%)</td><td>77 (20.4%)</td></tr><tr><td>Overall</td><td>51 (7.3%)</td><td>140 (21.6%)</td><td>11 (7.4%)</td><td>8 (5.1%)</td><td>29 (4.5%)</td><td>82 (12.8%)</td><td>74 (10.6%... |
eb336ad349a869dec796b92c4a1cab63b9980beee5db78f375e5fa8e3be4ee5d.png | simple | <table><tr><td> </td><td>Units</td><td>CN</td><td>MCI</td><td>AD</td><td>P-value</td></tr><tr><td>n</td><td>—</td><td>91</td><td>144</td><td>67</td><td>NA</td></tr><tr><td>Age</td><td>Years (s.d.)</td><td>75.74 (5.43)</td><td>74.85 (7.2)</td><td>74.57 (7.61)</td><td>0.502</td></tr><tr><td>Female</td><td><i>n</i> ... | <table><tr><td></td><td>Units</td><td>CN</td></tr><tr><td>n</td><td>—</td><td>91</td></tr><tr><td>Age</td><td>Years (s.d.)</td><td>75.74 (5.43)</td></tr><tr><td>Female</td><td>n (%)</td><td>46 (50.55)</td></tr><tr><td>Education</td><td>Years (s.d.)</td><td>15.67 (2.94)</td></tr><tr><td>APOE-ɛ4 +ve</td><td>n (%)</td><td... | <table><tr><td>MCI</td><td>AD</td><td>P-value</td></tr><tr><td>144</td><td>67</td><td>NA</td></tr><tr><td>74.85 (7.2)</td><td>74.57 (7.61)</td><td>0.502</td></tr><tr><td>47 (32.64)</td><td>29 (43.28)</td><td>0.021</td></tr><tr><td>15.91 (2.95)</td><td>15.01 (2.96)</td><td>0.123</td></tr><tr><td>75 (52.08)</td><td>46 (6... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.